RU2775712C2 - Methods and compositions for improving plant qualities - Google Patents

Abstract

FIELD: agriculture.

SUBSTANCE: invention relates to a composition for increasing nitrogen fixation in non-leguminous plants. Composition contains plant seed and non-intergeneric diazotrophic bacteria, including at least one genetic variation introduced into the genetic regulatory network of nitrogen fixation or genetic regulatory network of nitrogen assimilation, leading to one or several of the following: high expression or activity of nifH, high expression or activity of nifA, low expression or activity of nifL, and reduction in the activity of bifunctional glutamine synthetase in removing adenylyl transferase or adenylate. At least one genetic variation therein includes genetic material originating from the same genus as said non-intergeneric diazotrophic bacteria. One or more genetic variations also (A) constitutes a knock-out mutation, (B) a modification or deletion of a regulatory sequence of the target gene, or (C) includes an insertion of a heterologous regulatory sequence.

EFFECT: above bacteria produce 1% or more fixed nitrogen in a plant.

23 cl, 16 dwg, 10 tbl, 7 ex

Description

CROSS REFERENCE

[0001] This application claims priority to U.S. Provisional Application No. 62/192009, filed July 13, 2015, and U.S. Provisional Application No. 62/213567, filed September 2, 2015, each of which is hereby incorporated by reference in its entirety. .

FEDERALLY FUNDED STUDY STATEMENT

[0002] The present invention was made with the support of the Government of the United States of America in the form of grant SBIR 1520545 allocated by the National Science Foundation. The US government has certain rights in the subject matter described.

BACKGROUND OF THE INVENTION

[0003] Plants are associated with the microbiome by a common metabolome. The multidimensional relationship between a particular trait of an agricultural crop and its underlying metabolome is characterized by a relief with many local maxima. Optimizing from a smaller local maximum to another representing an improved trait by changing the influence of the microbiome on the metabolome may be desirable for a variety of reasons, such as crop optimization. Economically, environmentally and socially sustainable approaches to agriculture and food production are needed to meet the needs of a growing global population. The Food and Agriculture Organization of the United Nations predicts that to meet the needs of a growing population by 2050, total food production must increase by 70%, a task that is complicated by numerous factors, including declining fresh water resources, increasing competition for arable land, rising energy prices, rising production costs and similar demands to adapt crops to the pressures of a drier, hotter and more extreme global climate.

[0004] One area of interest is improving nitrogen fixation. Gaseous nitrogen (N ₂ ) is the main component of the Earth's atmosphere. In addition, elemental nitrogen (N) is an essential component of many of the chemical compounds that make up living organisms. However, many organisms cannot directly use _N2 to synthesize chemical compounds used in physiological processes such as growth and reproduction. To use N ₂ it is necessary that N ₂ be combined with hydrogen. The combination of hydrogen with N ₂ is referred to as nitrogen fixation. Nitrogen fixation, either chemically or biologically, requires a large amount of energy. In biological systems, the reaction that leads to nitrogen fixation is catalyzed by an enzyme known as nitrogenase. An important goal of nitrogen fixation research is to extend this phenotype to non-legumes, specifically to important agricultural grasses such as wheat, rice, and corn. Despite great progress in understanding the development of nitrogen-fixing symbiosis between nodule bacteria and legumes, the way to use this knowledge to induce nitrogen-fixing nodules in non-legumes is still unclear. Meanwhile, the challenge of providing sufficient additional sources of nitrogen, such as in fertilizers, will continue to grow along with the growing need to increase food production.

SUMMARY OF THE INVENTION

[0005] In light of the above, there is a need to improve plant traits conferred by the associated microbiome. The present invention solves this problem and also provides additional benefits. In certain cases, the targets for modulating the influence of microorganisms on the metabolome are the species that make up the microbiome and the genetics that determines them.

[0006] In one aspect, the present invention relates to a method for increasing nitrogen fixation in non-legume plants, wherein the method comprises exposing the plant to a plurality of bacteria, wherein each member of the plurality carries one or more genetic variations introduced into one or more genes or non-coding polynucleotides of the genetic regulatory network fixing or assimilating the nitrogen of the bacteria so that the bacteria become capable of fixing atmospheric nitrogen in the presence of exogenous nitrogen; where the bacteria are not intergeneric microorganisms; and where bacteria in planta produce 1% or more of fixed nitrogen in the plant.

[0007] In certain embodiments, the bacteria in planta produce 5% or more of fixed nitrogen in the plant. In certain embodiments, the bacteria in planta produce 10% or more fixed nitrogen in the plant.

[0008] In certain embodiments, the one or more genetic variations comprise an introduced regulatory sequence operably linked to said one or more genes of the nitrogen fixation or assimilation genetic regulatory network. In additional embodiments, the implementation of the regulatory sequence is a promoter. In further embodiments, the promoter is an inducible promoter. In certain embodiments, the bacteria do not contain a constitutive promoter operably linked to a gene for the nitrogen fixation or assimilation genetic regulatory network. In certain embodiments, the bacteria do not contain a constitutive promoter operably linked to a gene from the nif gene cluster.

[0009] In certain embodiments, the bacteria in planta secrete nitrogen-containing products of nitrogen fixation. In certain embodiments, the plurality of bacteria affecting the plant does not stimulate increased uptake of exogenous non-atmospheric nitrogen.

[0010] In certain embodiments, the plant is grown in soil from a field that has applied about 22.7 kg of nitrogen-containing fertilizer per acre, and where the nitrogen-containing fertilizer contains at least 5% nitrogen by weight. In further embodiments, the nitrogen-containing fertilizer contains ammonium or ammonium-containing molecules. In certain embodiments, the exogenous nitrogen is selected from a fertilizer containing one or more of glutamine, ammonia, ammonium, urea, nitrate, nitrite, ammonium-containing molecules, nitrate-containing molecules, and nitrite-containing molecules.

[0011] In certain embodiments, the plurality of bacteria includes at least two different species of bacteria. In certain embodiments, the plurality of bacteria includes at least two different strains of the same bacterial species. In certain embodiments, the plurality of bacteria are bacteria of the genus Enterobacter . In certain embodiments, the plurality of bacteria are endophytic, epiphytic, or rhizospheric. In certain embodiments, a plurality of bacteria colonize the plant such that the bacteria are present in the plant in an amount of at least 10 ⁵ cfu per gram of fresh plant mass.

[0012] In certain embodiments, one or more genes or non-coding polynucleotides of the bacterial nitrogen fixation or assimilation genetic regulatory network are selected from the group consisting of: nif A, nif L, ntr B, ntr C, polynucleotide encoding glutamine synthetase, gln A, gln B, gln K, drat , amt B, polynucleotide encoding glutaminase , gln D, gln E, nif J, nif H, nif D, nif K, nif Y, nif E, nif N, nif U, nif S, nif V , nif W, nif Z, nif M, nif F, nif B, and nif Q. In certain embodiments, one or more genetic variations are a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. In certain embodiments, one or more of the genetic variations (A) is a knockout mutation; (B) change or delete the regulatory sequence of the target gene or (C) include the insertion of a heterologous regulatory sequence.

[0013] In certain embodiments, the plant is a crop. In further embodiments, the crop is selected from sorghum, canola, tomato, strawberry, barley, rice, corn, and wheat. In further embodiments, the plant is a genetically modified organism. In additional embodiments, the plant is not a genetically modified organism. In certain embodiments, the plant is genetically engineered or bred to use nitrogen efficiently.

[0014] In one aspect, the present invention relates to a population of bacteria, including bacteria that carry one or more genetic variations introduced into one or more genes or non-coding polynucleotides of the genetic regulatory network of nitrogen fixation or assimilation of bacteria so that the bacteria become capable of atmospheric fixation nitrogen in the presence of exogenous nitrogen; where the bacteria are not intergeneric microorganisms; and wherein the bacteria in planta produce, in a plant grown in the presence of a population of bacteria, 1% or more of fixed nitrogen.

[0015] In certain embodiments, the bacteria in planta produce 5% or more of fixed nitrogen in the plant. In certain embodiments, the bacteria in planta produce 10% or more fixed nitrogen in the plant.

[0016] In certain embodiments, the one or more genetic variations comprise an introduced regulatory sequence operably linked to said one or more genes of the nitrogen fixation or assimilation genetic regulatory network. In additional embodiments, the implementation of the regulatory sequence is a promoter. In further embodiments, the promoter is an inducible promoter. In certain embodiments, the bacteria do not contain a constitutive promoter operably linked to a gene for the nitrogen fixation or assimilation genetic regulatory network. In certain embodiments, the bacteria do not contain a constitutive promoter operably linked to a gene in the nif gene cluster.

[0017] In certain embodiments, the bacteria in planta secrete nitrogen-containing products of nitrogen fixation. In certain embodiments, the plurality of bacteria affecting the plant does not stimulate increased uptake of exogenous non-atmospheric nitrogen. In certain embodiments, the exogenous nitrogen is selected from a fertilizer containing one or more of glutamine, ammonia, ammonium, urea, nitrate, nitrite, ammonium-containing molecules, nitrate-containing molecules, and nitrite-containing molecules.

[0018] In certain embodiments, the bacterial population includes at least two different species of bacteria. In certain embodiments, the bacterial population includes at least two different strains of the same bacterial species. In certain embodiments, the plurality of bacteria are bacteria of the genus Enterobacter . In certain embodiments, the plurality of bacteria are endophytic, epiphytic, or rhizospheric. In certain embodiments, a plurality of bacteria colonize the plant such that the bacteria are present in the plant in an amount of at least 10 ⁵ cfu per gram of fresh plant mass.

[0019] In certain embodiments, one or more genes or non-coding polynucleotides of the bacterial nitrogen fixation or assimilation genetic regulatory network are selected from the group consisting of: nif A, nif L, ntr B, ntr C, polynucleotide encoding glutamine synthetase, gln A, gln B, gln K, drat , amt B, polynucleotide encoding glutaminase , gln D, gln E, nif J, nif H, nif D, nif K, nif Y, nif E, nif N, nif U, nif S, nif V , nif W, nif Z, nif M, nif F, nif B, and nif Q. In certain embodiments, one or more genetic variations are a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. In certain embodiments, one or more of the genetic variations (A) is a knockout mutation; (B) change or delete the regulatory sequence of the target gene or (C) include the insertion of a heterologous regulatory sequence.

[0020] In certain embodiments, the plant is a crop. In further embodiments, the crop is selected from sorghum, canola, tomato, strawberry, barley, rice, corn, and wheat. In further embodiments, the plant is a genetically modified organism. In additional embodiments, the plant is not a genetically modified organism. In certain embodiments, the plant is genetically engineered or bred to use nitrogen efficiently.

[0021] In one aspect, the present invention relates to a composition containing a population of bacteria according to the present invention. In certain embodiments, the implementation of the composition contains a population of bacteria applied to the surface of the seeds. In certain embodiments, the composition is formulated as a liquid or powder.

[0022] In one aspect, the present invention provides an isolated bacterium deposited as ATCC Deposit Access No. PTA-122293 or PTA-122294.

[0023] In one aspect, the present invention relates to a non-intergeneric bacterium carrying one or more genetic variations introduced into one or more genes or non-coding polynucleotides of the bacterial nitrogen fixation or assimilation genetic regulatory network such that the bacterium becomes capable of atmospheric nitrogen fixation in the presence of exogenous nitrogen.

[0024] In certain embodiments, the one or more genetic variations comprise an introduced regulatory sequence operably linked to said one or more genes of the nitrogen fixation or assimilation genetic regulatory network. In additional embodiments, the implementation of the regulatory sequence is a promoter. In further embodiments, the promoter is an inducible promoter. In certain embodiments, the bacteria do not contain a constitutive promoter operably linked to a gene for the nitrogen fixation or assimilation genetic regulatory network. In certain embodiments, the bacteria do not contain a constitutive promoter operably linked to a gene in the nif gene cluster.

[0025] In certain embodiments, one or more genes or non-coding polynucleotides of the bacterial nitrogen fixation or assimilation genetic regulatory network are selected from the group consisting of: nif A, nif L, ntr B, ntr C, polynucleotide encoding glutamine synthetase, gln A, gln B, gln K, drat , amt B, polynucleotide encoding glutaminase , gln D, gln E, nif J, nif H, nif D, nif K, nif Y, nif E, nif N, nif U, nif S, nif V , nif W, nif Z, nif M, nif F, nif B, and nif Q. In certain embodiments, one or more genetic variations are a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. In certain embodiments, one or more of the genetic variations (A) is a knockout mutation; (B) change or delete the regulatory sequence of the target gene or (C) include the insertion of a heterologous regulatory sequence.

[0026] In certain embodiments, the bacterium is a bacterium of the genus Enterobacter . In certain embodiments, the bacterium is endophytic, epiphytic, or rhizospheric.

[0027] In one aspect, the present invention relates to a method for obtaining one or more bacteria. In one embodiment, the method comprises (a) isolating the bacteria from the tissue or soil of the first plant; (b) introducing a genetic variation (eg, one or more genetic variations) into one or more bacteria to produce one or more bacterial variants; (c) exposure of bacterial variants to a plurality of plants; (d) isolating the bacteria from the tissue or soil of one of the plurality of plants, wherein the plant from which the bacteria is isolated has an improved trait relative to other plants in the plurality of plants; and (e) repeating steps (b)-(d) with the bacteria isolated in step (d). The improved trait may be improved nitrogen fixation in the plant from which the bacteria is isolated and/or in the plants exposed to the bacteria. The genetic variation may be a variation in a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glnA, glnB, glnK, draT, amtB, glnD, glnE, nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ. The genetic variation may be a variation in a gene encoding a protein with a functionality selected from the group consisting of: glutamine synthetase, glutaminase, glutamine synthetase adenylate transferase, transcription activator, transcription antiactivator, pyruvate:flavodoxin oxidoreductase, flavodoxin, or ADP-D-ribosyltransferase NAD ⁺ : dinitrogenase reductase. In certain embodiments, the genetic variation is a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. The genetic variation may be a knockout mutation, deactivate or abolish the activity of a protein domain, change or abolish the regulatory sequence of the target gene, and/or include the insertion of a heterologous regulatory sequence. In certain embodiments, the implementation of the genetic variation includes the insertion of a regulatory sequence found in the genome of the species or genus of bacteria corresponding to the bacteria in which the genetic variation is carried out. The regulatory sequence may optionally be selected based on the level of gene expression in the bacterial culture or plant tissue. The genetic variation may be a random mutation at a random position, a random mutation at a target site, or a predetermined genetic variation specifically introduced at a target site. Genetic variation may include the insertion, deletion, or substitution of one or more nucleotides, or any combination of these. Genetic variation can be obtained by chemical mutagenesis. In certain embodiments, the method further comprises exposing the plants to biotic or abiotic stressors. In certain embodiments, the bacteria isolated after repeating steps (b)-(d) once or multiple times produce 1% or more (e.g., at least 2%, 5%) of 10% or more) nitrogen in a second plant of the same type. , as the first plant, or into a plant exposed to bacteria. Such production can also be achieved when the second plant is grown in the presence of a fertilizer supplemented with glutamine, ammonia, or other chemical nitrogen source. In certain embodiments, bacteria isolated after repeating steps (b)-(d) once or multiple times exhibit at least a 2-fold increase (e.g., at least a 5-fold increase) in nitrogen fixation compared to bacteria isolated from the first plants. The first plant or plants in the plurality of plants may be a crop, such as a plant selected from barley, rice, corn, wheat, sorghum, sweet corn, sugarcane, onions, tomatoes, strawberries, or asparagus. The first plant or plants in the plurality of plants may be a model plant, such as a plant selected from Setaria , Brachypodium , or Arabidopsis . In certain embodiments, step (a) further comprises performing a genetic analysis of the isolated bacteria. In certain embodiments, step (b) further comprises applying selection pressure to enrich for bacteria carrying the genetic variation and optionally isolating bacteria that have undergone selection pressure. Selection pressure may include cleavage of genomes with no genetic variation introduced at the target site, where the cleavage occurs within 100 nucleotides of the target site. Cleavage can be carried out with a site-specific nuclease, such as a nuclease selected from the group consisting of a zinc finger nuclease, a CRISPR nuclease, a TALE nuclease, or a meganuclease. In some instances, a CRISPR nuclease may be preferred. Bacteria isolated after a single or multiple repetition of steps (b)-(d) are endophytic, epiphytic or rhizospheric. Bacteria can be isolated from plant tissue (eg seeds). Bacteria can include bacteria from many different taxa. In certain embodiments, isolating the bacteria in step (a) comprises isolating the bacteria from the seeds of the first plant.

[0028] In one aspect, the present invention relates to a method for increasing nitrogen fixation in a plant. In one embodiment, the method includes exposing a plant to bacteria carrying one or more genetic variations introduced into one or more genes that regulate nitrogen fixation, where the bacteria produce 1% or more in the plant (e.g., at least 2%, 5% , 10% or more) nitrogen. Bacteria can produce nitrogen in the presence of fertilizer supplemented with glutamine, ammonia, or other chemical source of supplemental nitrogen. In certain embodiments, the genetic variation is a variation in a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glutamine synthetase, glnA, glnB, glnK, draT, amtB, glutaminase, glnD, glnE, nifJ, nifH, nifD , nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ. The genetic variation may be a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. In certain embodiments, the implementation of the genetic variation (a) is a knockout mutation; (b) alters or deletes the regulatory sequence of the target gene; or (c) includes the insertion of a heterologous regulatory sequence. Bacteria can be endophytic, epiphytic, or rhizospheric. In some cases, the bacteria are of the genus Enterobacter or Rahnella . Bacteria can include bacteria from many different taxa. In certain embodiments, the plant is a crop, such as a plant selected from sorghum, canola, tomato, strawberry, barley, rice, corn, and wheat. The plant may be a non-legume plant. The plant may be a genetically modified organism (GMO; for example, a plant whose genome has been altered to carry a heterologous gene), a non-GMO organism, or genetically engineered or bred to use nitrogen efficiently.

[0029] In one aspect, the present invention relates to a population of bacteria. In one embodiment, the bacterial population includes bacteria carrying one or more genetic variations introduced into one or more nitrogen fixation regulating genes, wherein the bacteria produce, in a plant grown in the presence of the bacterial population, 1% or more (e.g., at least 2%, 5%, 10% or more) nitrogen. Bacteria can produce nitrogen in the presence of fertilizer supplemented with glutamine, ammonia, or other chemical source of supplemental nitrogen. In certain embodiments, the genetic variation is a variation in a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glutamine synthetase, glnA, glnB, glnK, draT, amtB, glutaminase, glnD, glnE, nifJ, nifH, nifD , nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ. The genetic variation may be a mutation that results in one or more of: increased expression of nifA or glutaminase; reduced expression of nifL, ntrB, glutamine synthetase, glnB, glnK, draT, amtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. In certain embodiments, the implementation of the genetic variation (a) is a knockout mutation; (b) alters or deletes the regulatory sequence of the target gene; or (c) includes the insertion of a heterologous regulatory sequence. Bacteria can be endophytic, epiphytic, or rhizospheric. In some cases, the bacteria are of the genus Enterobacter or Rahnella . Bacteria can include bacteria from many different taxa.

[0030] In one aspect, the present invention relates to a composition containing a population of bacteria, such as a population of bacteria, as described herein. The composition may contain a population of bacteria applied to the surface of the seeds. In certain embodiments, the composition is formulated as a liquid or powder.

[0031] In one aspect, the present invention provides a bacterium with ATCC deposit accession number PTA-122293. In one aspect, the present invention relates to a bacterium with ATCC deposit access number PTA-122294.

INCLUDED AS A LINK

[0032] All publications, patents, and patent applications referenced herein are incorporated herein by reference to the same extent as if each particular publication, patent, or patent application were specifically and separately indicated for inclusion by reference.

BRIEF DESCRIPTION OF THE DRAWINGS

[0033] New features of the invention are described in detail in the appended claims. A better understanding of the features and advantages of the present invention may be obtained by reference to the following detailed description, which provides illustrative embodiments in which the basis of the invention is used, and to the accompanying figures, in which:

[0034] Figure 1A-B shows the enrichment and isolation of nitrogen fixing bacteria. (A) Nfb agar plates were used to isolate single colonies of nitrogen fixing bacteria. (B) Semi-solid Nfb agar poured into a Balch tube. The arrow points to the pellicle of enriched nitrogen-fixing bacteria.

[0035] Figure 2 shows an exemplary screening of nifH by PCR. In this screen, positive bands were observed at ≈350 bp. for two colonies. The lower bands are 7 primer dimers.

[0036] Figure 3 shows an example of PCR screening of colonies after CRISPR-Cas selection mutagenesis. CI006 colonies were screened with primers specific for the nifL locus. The expected wild-type PCR product is ≈2.2 kb, while the expected mutant is ≈1.1 kb. Seven out of ten screened colonies clearly showed the required deletion.

[0037] Figures 4A-D show the in vitro phenotypes of various strains. Acetylene recovery assay (ARA) activity of CI010 strain mutants ( Figure 4A ) and CI006 strain mutants ( Figure 4B ) grown in nitrogen fixation medium supplemented with 0 to 10 mM glutamine. The activity of the additional strains in ARA is shown in Figure 4C and the release profile of the two strains of ammonium over time is shown in Figure 4D .

[0038] Figure 5 shows the culture expression profile of 9 different genes in CI006 strains involved in diazotrophic nitrogen fixation. The numbers represent the amounts of each transcript. Various conditions are shown (0, 1, 10 mM glutamine and 0%, 10%, 20% atmospheric air in N ₂ ).

[0039] Figure 6 shows CI006 colonization of corn roots. Corn seedlings were inoculated with CI006 carrying the RFP expression plasmid. After two weeks of growth and maintenance of the plasmid by irrigating with the appropriate antibiotic, the roots were harvested and visualized by fluorescence microscopy. Colonization of the intercellular space of the roots can be observed.

[0040] Figure 7 shows the nitrogen obtained at the microbial level for the WT strain (CI050) and the optimized strain (CM002).

[0041] Figures 8 show the Micro-Tom fruit weight test setup.

[0042] Figure 9 shows the Micro-Tom screening of 10 strains for plant fetal weight gain. The results of six repetitions are presented. For column 3, p=0.07. For column 7, p=0.05.

[0043] Figures 10A-C show additional results for the activity of candidate microorganisms and other candidate mutants grown in nitrogen fixation media supplemented with 0 to 10 mM glutamine in ARA.

[0044] Figure 11 shows a double mutant that exhibits higher ammonia excretion than the single mutant from which it is derived.

[0045] Figure 12 shows the NDFA obtained from the ¹⁵ N gas capture experiment (reverse extrapolated using day of exposure) to determine NDFA in corn plants under fertilization conditions.

[0046] Figure 13 shows the NDFA value obtained from the ¹⁵ N gas capture experiment (back extrapolated using days of exposure) to determine NDFA in Setaria plants under fertilization conditions.

[0047] Figure 14A shows the degree of ¹⁵ N gas incorporation. Plants inoculated with the evolved strain showed an increase in ¹⁵ N gas incorporation compared to non-inoculated plants.

[0048] Figure 14B shows 4 weeks after planting, up to 7% of the nitrogen in plants inoculated with the evolved strain comes from microorganism-fixed nitrogen.

[0049] Figure 14C shows the increase in leaf area (and other biomass measurements, data not shown) in plants inoculated with the evolved strain compared to uninoculated plants or inoculated wild type plants.

[0050] Figure 15A depicts evolved strains that show significantly higher production of nifH in root tissue as determined by in planta transcriptome testing.

[0051] Figure 15B shows that the level of fixed nitrogen detected in plant tissue correlates with the level of colonization of that particular plant by the HoME-optimized strain.

[0052] Figure 16A is a soil structure map of various field soils tested for colonization. Soils, which initially were the source of a small number of microorganisms, are indicated by stars.

[0053] Figure 16B shows the colonization rate of strain 1 and strain 5 tested in four different soil types (circles). Both strains showed a relatively stable colonization profile in various soil types.

[0054] Figure 16C shows the colonization of strain 1 tested in field trials during the growing season. Strain 1 persisted in maize tissue up to 12 weeks after planting and began to show a decrease in colonization after that time.

DETAILED DESCRIPTION OF THE INVENTION

[0055] The terms "polynucleotide", "nucleotide", "nucleotide sequence", "nucleic acid", and "oligonucleotide" are used interchangeably. They refer to the polymeric form of nucleotides of any length, which are deoxyribonucleotides or ribonucleotides or their analogues. Polynucleotides may have any three-dimensional structure and may perform any function, known or unknown. Non-limiting examples of polynucleotides are the following: coding or non-coding regions of a gene or gene fragment, loci (locus) determined by linkage analysis, exons, introns, messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), small interfering RNA (siRNA), short hairpin RNA (shRNA), microRNA (miRNA), ribozymes, cDNA, recombinant polynucleotides, branched polynucleotides, plasmids, vectors, isolated DNA of any sequence, isolated RNA of any sequence, nucleic acid probes and primers. The polynucleotide may contain one or more modified nucleotides such as methylated nucleotides and nucleotide analogs. If present, modifications to the nucleotide structure may be provided before or after polymer assembly. Nucleotide sequences may be interrupted by non-nucleotide components. The polynucleotide can be further modified after polymerization, for example by conjugation with a labeled moiety.

[0056] "Hybridization" refers to a reaction in which one or more polynucleotides react to form a complex that is stabilized by hydrogen bonding between bases of nucleotide residues. Hydrogen bonding can occur by Watson-Crick base pairing, Hoogsteen bonding, or any other sequence-specific manner. The complex may contain two strands forming a duplex structure, three or more strands forming a multistrand complex, one self-hybridizing strand, or any combination of these. The hybridization reaction may be a step in a more complex process such as PCR initiation or enzymatic cleavage of a polynucleotide with an endonuclease. A second sequence that is complementary to the first sequence is referred to as a sequence "complementary" to the first sequence. The term "hybridizable" when applied to a polynucleotide refers to the ability of a polynucleotide to form a complex that is stabilized due to the formation of hydrogen bonds between bases of nucleotide residues in a hybridization reaction.

[0057] "Complementarity" refers to the ability of a nucleic acid to form hydrogen bond(s) with another nucleic acid sequence via conventional Watson-Crick or other non-traditional mating types. Complementarity percent refers to the percentage of residues in a nucleic acid molecule that can form hydrogen bonds (e.g., via Watson-Crick base pairing) with a second nucleic acid sequence (e.g., 5, 6, 7, 8, 9, 10 out of 10 are complementarity 50%, 60%, 70%, 80%, 90% and 100% respectively). "Perfect complementarity" means that all consecutive residues of a nucleic acid sequence form hydrogen bonds with the same number of consecutive residues in a second nucleic acid sequence. As used herein, "substantially complementary" refers to a degree of complementarity that is at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, 98 %, 99% or 100% on areas 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40 , 45, 50 or more nucleotides, or refers to two nucleic acids that hybridize under stringent conditions. Sequence identity, for example for purposes of evaluating percent complementarity, can be determined by any suitable alignment algorithm, including but not limited to the Needleman-Wunsch algorithm (see, for example, the EMBOSS Needle alignment tool available at www.ebi.ac.uk/Tools/psa /emboss_needle/nucleotide.html, optionally with default settings), BLAST algorithm (see for example the BLAST aligner available at blast.ncbi.nlm.nih.gov/Blast.cgi, optionally with default settings), or Smith's algorithm -Waterman (see for example the EMBOSS Water alignment tool available at www.ebi.ac.uk/Tools/psa/emboss_water/nucleotide.html, optionally with default settings). The optimal alignment can be estimated using any suitable parameters of the selected algorithm, including the default parameters.

[0058] Generally, "stringent hybridization conditions" refer to conditions under which a nucleic acid that is complementary to a target sequence preferentially hybridizes to the target sequence and does not substantially hybridize to non-target sequences. As a rule, stringent conditions are sequence dependent and vary depending on a number of factors. Generally, the longer a sequence is, the higher is the temperature at which the sequence specifically hybridizes to its target sequence. Non-limiting examples of stringent conditions are detailed in Tijssen (1993), Laboratory Technniques In Biochemistry And Molecular Biology-Hybridization With Nucleic Acid Probes Part I, Second Chapter "Overview of principles of hybridization and the strategy of nucleic acid probe assay", Elsevier, N.Y.

[0059] As used herein, "expression" refers to the process by which a polynucleotide is transcribed from a DNA template (e.g. into an mRNA or other RNA transcript) and/or the process by which the transcribed mRNA is then translated into peptides, polypeptides or squirrels. The transcripts and encoded polypeptides can be collectively referred to as a "gene product". If the polynucleotide is derived from genomic DNA, expression may involve mRNA splicing in a eukaryotic cell.

[0060] The terms "polypeptide", "peptide", and "protein" are used interchangeably herein to refer to polymers of amino acids of any length. The polymer may be linear or branched, it may contain modified amino acids, and it may be interrupted by non-amino acid regions. The terms also include a modified polymer of amino acids; for example, by disulfide bond formation, glycosylation, lipidation, acetylation, phosphorylation, or any other manipulation such as conjugation with a labeled moiety. As used herein, the term "amino acid" includes natural and/or non-natural or synthetic amino acids, including glycine and D or L optical isomers, and amino acid analogs and peptidomimetics.

[0061] As used herein, the term "about" is used as a synonym for the term "about". For illustration, the use of the term "about" in relation to the amount means that the values are slightly outside the specified values, for example, plus or minus from 0.1% to 10%.

[0062] The term "biologically pure culture" or "substantially pure culture" refers to a culture of the bacterial species described herein that does not contain other bacterial species in quantities sufficient to interfere with the replication of the culture or detectable by standard bacteriological methods.

[0063] "Plant productivity" generally refers to any measure of plant growth or development that is the reason the plant is grown. For food crops such as cereals or vegetables, "plant productivity" may refer to the yield of cereals or fruits harvested from a particular crop. As used herein, improved plant productivity refers broadly to improving the yield of grains, fruits, flowers or other plant parts harvested for various purposes, improving the growth of plant parts including stems, leaves and roots, promoting plant growth, maintaining a high chlorophyll content in leaves, increase in the number of fruits or seeds, increase in the weight of a single fruit or seed, decrease in NO ₂ emissions due to reduced use of nitrogen fertilizers, and similar improvements in plant growth and development.

[0064] Microorganisms in and around food crops can affect the traits of those crops. Plant traits that can be affected by microorganisms include: yield (eg, grain production, biomass production, fruit development, flower structure); nutrition (eg intake of nitrogen, phosphorus, potassium, iron, micronutrients); the ability to control abiotic stress (eg drought tolerance, salt tolerance, heat tolerance) and the ability to control biotic stress (eg pests, weeds, insects, fungi and bacteria). Strategies for modifying crop traits include: increasing concentrations of key metabolites; change in the temporal dynamics of the impact of microorganisms on key metabolites; linking the production/destruction of metabolites by microorganisms with new environmental parameters; reducing unwanted metabolites and improving the balance of metabolites or conditioning proteins.

[0065] As used herein, "regulatory sequence" refers to an operator, promoter, silencer, or terminator.

[0066] As used herein, " in planta " means in a plant, wherein the plant further includes leaves, roots, stems, seeds, ovules, pollen, flowers, fruits, and the like.

[0067] In certain embodiments, natural or endogenous regulatory sequences of the genes of the present invention are replaced with one or more intrageneric regulatory sequences.

[0068] As used herein, "administered" refers to administration through modern biotechnology, not natural administration.

[0069] In certain embodiments, the implementation of the bacteria of the present invention is modified so that they are not natural bacteria.

[0070] In certain embodiments, the bacteria of the present invention are present in the plant in an amount of at least 10 ³ CFU, 10 ⁴ CFU, 10 ⁵ CFU, 10 ⁶ CFU, 10 ⁷ CFU, 10 ⁸ CFU, 10 ⁹ CFU, 10 ¹⁰ CFU , 10 ¹¹ CFU or 10 ¹² CFU per gram wet or dry weight of the plant. In certain embodiments, the bacteria of the present invention are present in the plant in an amount of at least about 10 ³ CFU, about 10 ⁴ CFU, about 10 ⁵ CFU, about 10 ⁶ CFU, about 10 ⁷ CFU, about 10 ⁸ CFU, about 10 ⁹ CFU , approximately 10 ¹⁰ CFU, approximately 10 ¹¹ CFU or approximately 10 ¹² CFU per gram of wet or dry weight of the plant. In certain embodiments, the bacteria of the present invention are present in the plant in an amount of at least 10 ³ to 10 ⁹ , 10 ³ to 10 ⁷ , 10 ³ to 10 ⁵ , 10 ⁵ to 10 ⁹ , 10 ⁵ to 10 ⁷ , from 10 ⁶ to 10 ¹⁰ , from 10 ⁶ to 10 ⁷ CFU per gram of wet or dry weight of the plant.

[0071] Fertilizers and exogenous nitrogen of the present invention may include the following nitrogen-containing molecules: ammonium, nitrate, nitrite, ammonia, glutamine, etc. The nitrogen sources of the present invention may include anhydrous ammonia, ammonium sulfate, urea, diammonium phosphate, formaldehyde urea, monoammonium phosphate, ammonium nitrate, liquid nitrogen fertilizers, calcium nitrate, potassium nitrate, sodium nitrate, and the like.

[0072] As used herein, "exogenous nitrogen" refers to non-atmospheric nitrogen readily available in the soil, field, or growing medium that is present under conditions without nitrogen restriction, including ammonia, ammonium, nitrate, nitrite, urea, uric acid, ammonic acids, etc.

[0073] As used herein, "non-limiting nitrogen conditions" refers to non-atmospheric nitrogen available in soil, field, environments at concentrations greater than about 4 mM nitrogen as described in Kant et al. (2010. J. Exp. Biol. 62(4):1499-1509), incorporated herein by reference.

[0074] As used herein, an "intergeneric microorganism" is a microorganism that is formed by the deliberate combination of genetic material originally isolated from organisms of different taxonomic genera. Interchangeably with "intergeneric microorganism" you can use "intergeneric mutant". An exemplary "intergeneric microorganism" includes a microorganism containing a mobile genetic element that is first identified in a microorganism belonging to a genus other than the recipient microorganism. Additional explanation can be found at 40 C.F.R., among other things. 725.3.

[0075] As used herein, an "intrageneric microorganism" is a microorganism that is formed by an intentional combination of genetic material originally isolated from organisms of the same taxonomic genus. Interchangeably with "intrageneric microorganism" you can use "intrageneric mutant".

[0076] As used herein, "introduced genetic material" means genetic material that is added to the genome of the recipient and that remains in the genome of the recipient as a component.

[0077] In certain embodiments, the genetic regulatory network for nitrogen fixation and assimilation comprises polynucleotides encoding genes and non-coding sequences that direct, modulate, and/or regulate nitrogen fixation and/or assimilation by microorganisms, and may comprise nif cluster polynucleotide sequences (e.g., nif A, nif B, nif C,....... nifZ ), polynucleotides encoding nitrogen metabolism regulating protein C, polynucleotides encoding nitrogen metabolism regulating protein B, gln cluster polynucleotide sequences (e.g. gln A and glnD ), dra T and ammonium transporters/permeases.

[0078] In certain embodiments, the fertilizer of the present invention contains at least 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16% , 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33 %, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66% , 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83 %, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% nitrogen by weight.

[0079] In certain embodiments, the fertilizer of the present invention contains at least about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13% , approximately 14%, approximately 15%, approximately 16%, approximately 17%, approximately 18%, approximately 19%, approximately 20%, approximately 21%, approximately 22%, approximately 23%, approximately 24%, approximately 25%, approximately 26%, approximately 27%, approximately 28%, approximately 29%, approximately 30%, approximately 31%, approximately 32%, approximately 33%, approximately 34%, approximately 35%, approximately 36%, approximately 37%, approximately 38% , approximately 39%, approximately 40%, approximately 41%, approximately 42%, approximately 43%, approximately 44%, approximately 45%, approximately 46%, approximately 47%, approximately 48%, approximately 49% , approximately 50%, approximately 51%, approximately 52%, approximately 53%, approximately 54%, approximately 55%, approximately 56%, approximately 57%, approximately 58%, approximately 59%, approximately 60%, approximately 61%, approximately 62%, approximately 63%, approximately 64%, approximately 65%, approximately 66%, approximately 67%, approximately 68%, approximately 69%, approximately 70%, approximately 71%, approximately 72%, approximately 73%, approximately 74% , approximately 75%, approximately 76%, approximately 77%, approximately 78%, approximately 79%, approximately 80%, approximately 81%, approximately 82%, approximately 83%, approximately 84%, approximately 85%, approximately 86%, approximately 87%, approximately 88%, approximately 89%, approximately 90%, approximately 91%, approximately 92%, approximately 93%, approximately 94%, approximately 95%, approximately 96%, approximately 97%, approximately 98% or approximately 99% nitrogen by mass.

[0080] In certain embodiments, the fertilizer of the present invention contains about 5% to 50%, about 5% to 75%, about 10% to 50%, about 10% to 75%, about 15% to 50% %, approximately 15% to 75%, approximately 20% to 50%, approximately 20% to 75%, approximately 25% to 50%, approximately 25% to 75%, approximately 30% to 50%, about 30% to 75%, about 35% to 50%, about 35% to 75%, about 40% to 50%, about 40% to 75%, about 45% to 50%, about 45% to 75% or about 50% to 75% nitrogen by weight.

[0081] In certain embodiments, the increase in nitrogen fixation and/or the production of 1% or more nitrogen in a plant is determined relative to control plants that have not been exposed to the bacteria of the present invention. All increases or decreases in bacteria are determined relative to control plants. All increases or decreases in plants are measured relative to control plants.

[0082] As used herein, a "constitutive promoter" is a promoter that is active under most conditions and/or during most stages of development. There are several advantages to using constitutive promoters in expression vectors used in biotechnology, for example: high production of proteins used to select transgenic cells or organisms; high level of expression of reporter proteins or selectable markers, providing simple detection and quantitative analysis; a high level of transcription factor production, which is part of the transcription regulation system; production of compounds that require ubiquitous activity in the body; and the production of compounds that are essential at all stages of development. Non-limiting exemplary constitutive promoters include the CaMV 35S promoter, opine promoters, ubiquitin promoter, alcohol dehydrogenase promoter, and the like.

[0083] As used herein, a "non-constitutive promoter" is a promoter that is active under certain conditions, in certain cell types, and/or during certain stages of development. For example, tissue-specific, tissue-preferred, cell-type-specific, cell-type-preferred, inducible, and developmentally controlled promoters are non-constitutive promoters. Examples of developmentally controlled promoters include promoters that preferentially initiate transcription in certain tissues.

[0084] As used herein, an "inducible" or "repressible" promoter is a promoter that is under the control of chemicals or environmental factors. Examples of environmental conditions that can affect transcription by inducible promoters include anaerobic conditions, certain chemicals, presence of light, acidic or basic conditions, and so on.

[0085] As used herein, a "tissue-specific" promoter is one that initiates transcription only in certain tissues. Unlike constitutive gene expression, tissue-specific expression is the result of several interacting levels of gene regulation. Thus, in the art, it is sometimes preferable to use promoters from homologous or closely related species to achieve efficient and reliable expression of transgenes in specific tissues. This is one of the main reasons for the large number of tissue-specific promoters isolated from specific tissues found both in the scientific and patent literature.

[0086] As used herein, the term "operably linked" refers to the association of nucleic acid sequences in one nucleic acid fragment such that the function of one is controlled by the other. For example, a promoter is operably linked to a coding sequence when it can regulate the expression of that coding sequence (ie, that coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in either sense or antisense orientation. In another example, complementary RNA regions of the invention may be operably linked, directly or indirectly, 5' to the target mRNA, or 3' to the target mRNA, or to the target mRNA, or the first complementary region. located on the 5' side, and its complementary region is located on the 3' side of the target mRNA

[0087] One of the traits that can be targeted for regulation by the methods described herein is nitrogen fixation. Nitrogen fertilizers are the biggest operating cost on farms and a major driver of higher yields in row crops such as corn and wheat. This document describes microbial waste products that can deliver renewable forms of nitrogen to non-legume crops. Although some endophytes have the genetic factors necessary for nitrogen fixation in pure crop, the main technical problem is that endophytes of wild-type cereals and grasses stop fixing nitrogen in fertilized fields. The use of chemical fertilizers and residual nitrogen levels in field soils signal the microorganism to turn off the biochemical pathway of nitrogen fixation.

[0088] Development of a microorganism capable of fixing and transferring nitrogen to corn in the presence of fertilizer requires changes at the transcriptional and post-translational levels of the nitrogen fixation regulatory network. To this end, this document describes the microorganism host evolution (HoME) technology, which allows for the directed evolution of regulatory networks and obtaining new phenotypes. Also described herein are unique, proprietary libraries of nitrogen-fixing endophytes isolated from maize, together with extensive "omics" data on microbial-host interactions under various environmental conditions such as nitrogen deficiency and nitrogen excess. This provides a directed evolution of the genetic regulatory network of endophytes in the direction of obtaining microorganisms that actively fix nitrogen even in the presence of fertilizer in the field. Also described in this paper is an assessment of the industrial potential of derived microorganisms that colonize corn root tissues and produce nitrogen in fertilized plants, and an assessment of the compatibility of endophytes with standard formulation technologies and various soils to determine the possibility of integrating microorganisms into modern nitrogen control strategies.

[0089] To use elemental nitrogen (N) for chemical synthesis, living forms combine gaseous nitrogen (N ₂ ) available in the atmosphere with hydrogen in a process known as nitrogen fixation. Due to the energy-intensive nature of biological nitrogen fixation, diazotrophs (bacteria and archaea that fix atmospheric gaseous nitrogen) in the course of evolution have developed a developed and tight regulation of the nif gene cluster in response to environmental oxygen and available nitrogen. The Nif genes encode enzymes involved in nitrogen fixation (such as the nitrogenase complex) and proteins that regulate nitrogen fixation. Shamseldin (2013. Global J. Biotechnol. Biochem. 8(4):84-94) provides a detailed description of the nif genes and their products and is incorporated herein by reference. Methods for producing a trait-improved plant are described herein, including isolating bacteria from a first plant, introducing a genetic variation in the nif gene of the isolated bacteria, exposing the bacteria variants to a second plant, isolating bacteria from a second plant with an improved trait relative to the first plant, and repeating the steps with the bacteria. isolated from the second plant.

[0090] In Proteobacteria , the regulation of nitrogen fixation is centered around the factor σ ⁵⁴ dependent enhancer-binding protein NifA, a positive transcriptional regulator of the nif cassette. Intracellular levels of active NifA control two key factors: transcription of the nifLA operon and inhibition of NifA activity by protein–protein interaction with NifL. Both of these processes respond to intracellular glutamine levels through a signaling cascade of PII proteins. This cascade is mediated by GlnD, which directly determines glutamine levels and catalyzes the uridylation or deuridylation of two PII regulatory proteins, GlnB and GlnK, in response to the absence or presence of bound glutamine, respectively. Under conditions of excess nitrogen, unmodified GlnB signals the deactivation of the nifLA promoter. However, under conditions of nitrogen restriction, post-translational modification of GlnB occurs, which inhibits its activity and leads to transcription of the nifLA operon. Thus, there is a tight control of nifLA transcription in response to environmental nitrogen through the signaling cascade of PII proteins. At the post-translational level of NifA regulation, GlnK inhibits the NifL/NifA interaction depending on the total level of free GlnK in the cell.

[0091] Transcription of NifA occurs from the operonnifLA, whose promoter activates phosphorylated NtrC, another σ-dependent⁵⁴ regulator. The NtrC phosphorylation state is mediated by NtrB histidine kinase, which interacts with deuridylated GlnB but not with uridylated GlnB. Under conditions of excess nitrogen, a high intracellular level of glutamine leads to deuridylation of GlnB, which then interacts with NtrB to deactivate its phosphorylase activity and activate its phosphatase activity, which leads to dephosphorylation of NtrC and deactivation of the promoter.nifLA. However, under conditions of nitrogen restriction, a low level of intracellular glutamine leads to uridylation of GlnB, which inhibits its interaction with NtrB and ensures NtrC phosphorylation and operon transcription.nifLA. Thus, there is a tight control of expressionnifLA in response to environmental nitrogen through signaling cascade of PII proteins. All ofnifA, ntrB, ntrC andglnB are genes that can be mutated in the ways described herein.

[0092] There is also post-translational regulation of NifA activity in response to environmental nitrogen, typically through NifL-mediated inhibition of NifA activity. As a rule, the interaction between NifL and NifA is influenced by the signaling cascade of PII proteins through GlnK, although the nature of interactions between GlnK and NifL/NifA in diazotrophs varies considerably. In Klebsiella pneumoniae , both forms of GlnK inhibit the NifL/NifA interaction, and the interaction between GlnK and NifL/NifA is measured by the total level of free GlnK in the cell. Under conditions of excess nitrogen, deuridylated GlnK interacts with the ammonia transporter AmtB, which serves to block ammonia uptake by AmtB and sequester GlnK on the membrane, allowing NifA to be inhibited by NifL. On the other hand, in Azotobacter vinelandii , NifL/NifA interaction and NifA inhibition require interaction with deuridylated GlnK, while uridylation of GlnK inhibits this interaction with NifL. In diazotrophs lacking the nifL gene, there is evidence that inhibition of NifA activity occurs directly upon interaction with deuridylated forms of GlnK and GlnB under conditions of excess nitrogen. Regardless of the mechanism, post-translational inhibition of NifA is an important regulator of the nif cluster in most known diazotrophs. Additionally, genes that can be mutated in the methods described herein are nifL, amtB and glnK .

[0093] In addition to regulating transcription of the nif gene cluster, many diazotrophs have evolved a mechanism for direct post-translational modification and inhibition of the nitrogenase enzyme itself, known as nitrogenase shutdown. It is mediated by ADP-ribosylation of the Fe protein (NifH) under conditions of excess nitrogen, which disrupts its interaction with the MoFe (NifDK) protein complex and eliminates nitrogenase activity. DraT catalyzes the ADP-ribosylation of the Fe protein and the shutdown of nitrogenase, while DraG catalyzes the removal of ADP-ribose and the reactivation of nitrogenase. As in the case of nifLA transcription and NifA inhibition, nitrogenase shutdown also regulates the signaling cascade of PII proteins. Under conditions of excess nitrogen, deuridylated GlnB interacts with DraT and activates it, while deuridylated GlnK interacts with DraG and AmtB to form a complex, sequestering DraG on the membrane. Under conditions of nitrogen restriction, the uridylated forms of GlnB and GlnK do not interact with DraT and DraG, respectively, leading to DraT inactivation and DraG diffusion to the Fe protein, where it removes ADP-ribose and activates nitrogenase. The methods described herein also provide for the introduction of genetic variations in the nifH, nifD, nifK and draT genes .

[0094] Although some endophytes have the ability to fix nitrogen in vitro , often these genetic factors are suppressed in the field by high levels of exogenous chemical fertilizers. To facilitate nitrogen fixation in the field, the determination of exogenous nitrogen levels and the expression of the nitrogenase enzyme can be separated. Improving the total nitrogenase activity over time further contributes to an increase in nitrogen production for crop use. Specific targets of genetic variation to facilitate field nitrogen fixation by the methods described herein include one or more genes selected from the group consisting of nifA, nifL, ntrB, ntrC, glnA, glnB, glnK, draT, amtB , gln D , glnE, nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ .

[0095] An additional target of genetic variation to facilitate nitrogen fixation in the field by the methods described herein is the NifA protein. As a rule, the NifA protein is an activator of the expression of nitrogen fixation genes. Increasing NifA production (either constitutively or under high ammonia conditions) overrides the natural way of determining ammonia levels. In addition, a decrease in the production of NifL proteins, a known NifA inhibitor, also leads to an increase in the level of free active NifA. In addition, an increase in the level of transcription of the nifAL operon (constitutively or under conditions of high ammonia content) also leads to an increase in the total level of NifA proteins. An increased level of nifAL expression is achieved by changing the promoter itself or by reducing the expression of NtrB (part of the ntrB and ntrC signaling cascade, which can initially lead to the shutdown of the nifAL operon under conditions of high nitrogen content). The high level of NifA achieved by these or any other methods described herein increases the activity of nitrogen fixation by endophytes.

[0096] Another target of genetic variation to facilitate nitrogen fixation in the field by the methods described herein is the GlnD/GlnB/GlnK PII signaling cascade. The intracellular level of glutamine determines the PII GlnD/GlnB/GlnK signaling cascade. GlnD active site mutations that abolish GlnD uridylate scavenging activity disrupt the nitrogen detection cascade. In addition, a decrease in the concentration of GlnB closes the cascade for determining the level of glutamine. These mutations "trick" the cells into detecting conditions of nitrogen restriction, thus increasing the level of nitrogen fixation activity.

[0097] Also targeted by genetic variation to facilitate nitrogen fixation in the field by the methods described herein is the amtB protein. The uptake of ammonia from the environment can be reduced by reducing the expression level of the amtB protein. Without intracellular ammonia, the endophyte is unable to detect high levels of ammonia, which prevents the downregulation of nitrogen fixation genes. Any ammonia entering the intracellular compartment is converted to glutamine. Intracellular glutamine levels are the primary means of determining nitrogen levels. A decrease in intracellular glutamine levels prevents cells from detecting high levels of ammonia in the environment. This can be done by increasing the expression level of glutaminase, the enzyme that converts glutamine to glutamate. In addition, the level of intracellular glutamine can also be reduced by reducing the level of glutamine synthetase (an enzyme that converts ammonia to glutamine). Diazotrophs rapidly assimilate fixed ammonia into glutamine and glutamate for use in cellular processes. Violation of ammonia assimilation can ensure the removal of fixed nitrogen for export from the cell in the form of ammonia. Fixed ammonia is predominantly assimilated to glutamine by glutamine synthetase (GS) encoded by glnA and then to glutamate by glutaminoxoglutarate aminotransferase (GOGAT). In certain examples, glnS encodes for glutamine synthetase. GS is post-translationally regulated by GS adenylyl transferase (GlnE), a bifunctional enzyme encoded by glnE that catalyzes adenylation and deadenylation of GS due to the activity of its adenylyl transferase (AT) and adenylyl retracting (AR) domains, respectively. Under conditions of nitrogen restriction, glnA is expressed and the AR domain of GlnE deadenylates GS, providing its activity. Under conditions of excess nitrogen, glnA expression is turned off and glutamine allosterically activates the AT domain of GlnE, which causes adenylation and deactivation of GS.

[0098] In addition, the draT gene can also be targeted by genetic variation to facilitate nitrogen fixation in the field by the methods described herein. After the cell produces nitrogen fixation enzymes, another level at which the cell negatively regulates fixation activity under high nitrogen conditions is nitrogenase shutdown. This switch-off can be eliminated by reducing the level of DraT expression.

[0099] Methods for imparting new phenotypes to microorganisms can be carried out at the transcriptional, translational, and post-translational levels. The transcriptional level includes changes in the promoter (such as a change in affinity for the sigma factor or transcription factor binding sites, including the deletion of all or part of the promoter) or a change in transcription terminators and attenuators. The translational level includes changes in ribosome binding sites and changes in mRNA degradation signals. The post-translational level includes mutations in the active sites of enzymes and changes in protein-protein interactions. These changes can be made in a variety of ways. Reducing the level of expression (or completely eliminating) can be done by replacing the natural ribosome binding site (RBS) or promoter with others with less strength/efficiency. The ATG start sites can be replaced with GTG, TTG, or CTG start codons, resulting in a decrease in the translational activity of the coding region. Complete elimination of expression can be achieved by knockout (deletion) of the coding region of the gene. An open reading frame (ORF) shift is likely to result in a premature stop codon in the ORF, thus resulting in a non-functional truncated product. Similarly, in-frame insertion of stop codons also results in a non-functional truncated product. The addition of a disruption tag to the N- or C-terminus can also be carried out to reduce the effective concentration of a particular gene.

[0100] Conversely, a certain level of expression of the genes described herein can be achieved using stronger promoters. To ensure high promoter activity under high nitrogen conditions (or any other conditions), a whole genome transcription profile under high nitrogen conditions can be obtained, and active promoters with the desired transcription level can be selected from this data set to replace the weak promoter. To improve translation initiation efficiency, weak start codons can be replaced with an ATG start codon. It is also possible to replace weak ribosome binding sites (RBS) with other RBSs with improved translation initiation efficiency. In addition, site-directed mutagenesis can also be performed to change the activity of the enzyme.

[0101] An increase in the level of nitrogen fixation that occurs in a plant can lead to a decrease in the amount of chemical fertilizers needed to produce crops and a decrease in greenhouse gas emissions (eg, monovalent nitric oxide).

Serial reseeding

[0102] Obtaining bacteria to improve plant traits (eg, nitrogen fixation) can be achieved through serial reseeding. In addition to identifying bacteria and/or compositions capable of providing one or more improved traits in one or more plants, it can be done by selecting plants with a particular improved trait that is affected by the microbial flora. One way to obtain bacteria to improve a trait of a plant includes the steps of: (a) isolating the bacteria from the tissue or soil of the first plant; (b) introducing a genetic variation into one or more bacteria to produce one or more bacterial variants; (c) exposure of bacterial variants to a plurality of plants; (d) isolating the bacteria from the tissue or soil of one of the plurality of plants, wherein the plant from which the bacteria is isolated has an improved trait relative to other plants in the plurality of plants; and (e) repeating steps (b)-(d) with bacteria isolated from the trait-improved plant (step (d)). Steps (b)-(d) can be repeated any number of times (eg, once, twice, three times, four times, five times, ten times or more) until the improved plant trait reaches the desired level. Further, the plurality of plants may be more than two plants, such as 10 to 20 plants, or 20 or more, 50 or more, 100 or more, 300 or more, 500 or more, or 1000 or more plants.

[0103] In addition to obtaining a plant with an improved trait, a population of bacteria is obtained containing bacteria carrying one or more genetic variations introduced in one or more genes (for example, genes that regulate nitrogen fixation). By repeating the above steps, a bacterial population can be obtained that contains the most appropriate members of the population that correlates with the plant trait of interest. Bacteria in this population can be identified and their beneficial properties determined, for example, through genetic and/or phenotypic analysis. Genetic analysis can be performed on bacteria isolated in step (a). Phenotypic and/or genotypic information can be obtained using methods including: high-throughput screening of plant-derived chemical components, sequencing methods including high-throughput sequencing of genetic material, differential display methods (including DDOT-PCR and DD-PCR), nucleic acid microarray methods, RNA-sec (shotgun sequencing of the whole genome) and qPCR-RT (quantitative PCR with real-time detection). The information obtained can be used to obtain population profiling information about the identification characteristics and activity of the bacteria present, for example, phylogenetic analysis or microarray-based screening of nucleic acids encoding components of rRNA operons or other taxonomically informative loci. Examples of taxonomically informative loci include 16S rRNA gene, 23S rRNA gene, 5S rRNA gene, 5.8S rRNA gene, 12S rRNA gene, 18S rRNA gene, 28S rRNA gene, gyrB gene, rpoB gene, fusA gene, recA gene, coxl gene, nifD. Examples of taxonomic profiling methods for determining taxa present in a population are described in US20140155283. Identification of bacteria may include characterizing the activity of one or more genes or one or more signal transduction pathways, for example genes associated with the nitrogen fixation pathway. also in bacterial populations there may be synergistic interactions (when two components, when combined, increase the desired effect more than additively) between different bacterial species.

[0104] The genetic variation may be a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glnA, glnB, glnK, draT, amtB , gln D, glnE, nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ . The genetic variation may be a variation in a gene encoding a protein with a functionality selected from the group consisting of: glutamine synthetase, glutaminase, glutamine synthetase adenylate transferase, transcription activator, transcription antiactivator, pyruvate:flavodoxin oxidoreductase, flavodoxin, or ADP-D-ribosyltransferase NAD ⁺ : dinitrogenase reductase. The genetic variation may be a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. The introduction of genetic variation may include the insertion and/or deletion of one or more nucleotides at the target site, for example, 1, 2, 3, 4, 5, 10, 25, 50, 100, 250, 500 or more nucleotides. A genetic variation introduced into one or more bacteria by the methods described herein may be a knockout mutation (e.g., promoter deletion, premature stop codon insertion or deletion, entire gene deletion), or it may be a deletion or elimination of protein domain activity (for example, a point mutation affecting the active site, or deletion of a portion of a gene encoding a significant portion of a protein product), or it may be a change or deletion of the regulatory sequence of the target gene. It is also possible to insert one or more regulatory sequences, including heterologous regulatory sequences and regulatory sequences found in the genome of the bacterial species or genus corresponding to the bacteria in which the genetic variation is being carried out. In addition, regulatory sequences can be selected based on the level of gene expression in a bacterial culture or plant tissue. The genetic variation may be a predetermined genetic variation that is specifically introduced into the target site. The genetic variation may be a random mutation in the target area. A genetic variation may be an insertion or deletion of one or more nucleotides. In some cases, many different genetic variations (eg, 2, 3, 4, 5, 10 or more) are introduced into one or more of the isolated bacteria before the bacteria are exposed to the plants to evaluate the improvement of a trait. The plurality of genetic variations may be any of the types described above, the same or different types, and any combination thereof. In some cases, a plurality of different genetic variations are performed sequentially, conducting the first genetic variation after the first isolation step, the second genetic variation after the second isolation step, and so on. so as to accumulate many genetic variations in bacteria gradually providing improved traits in associated plants.

[0105] In general, the term "genetic variation" refers to any change introduced into a polynucleotide sequence relative to a reference polynucleotide, such as a reference genome or portion thereof, or a reference gene or portion thereof. A genetic variation may be referred to as a "mutation" and a sequence or organism containing the genetic variation may be referred to as a "genetic variant" or "mutant". Genetic variations can have a number of effects, such as an increase or decrease in a particular type of biological activity, the inclusion of gene expression, metabolism and cell signaling. Genetic variations can be specifically introduced into the target area or introduced randomly. A number of molecular biology tools and techniques are available for introducing genetic variation. For example, genetic variation can be introduced by polymerase chain reaction mutagenesis, site-directed mutagenesis, saturation mutagenesis, fragment shuffling mutagenesis, homologous recombination, CRISPR/Cas9 systems, chemical mutagenesis, and combinations thereof. Chemical methods for introducing genetic variation include exposing the DNA to a chemical mutagen such as ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS), N-nitrosourea (EN U), N-methyl-N-nitro-N'-nitrosoguanidine, -oxide, diethyl sulfate, benzopyrene, cyclophosphamide, bleomycin, triethylmelamine, monomeric acrylamide, nitrogen mustard, vincristine, diepoxyalkanes (e.g. diepoxybutane), ICR-170, formaldehyde, procarbazine hydrochloride, ethylene oxide, dimethylnitrosamine, 7,12 dimethylbenz(a)anthracene, chlorambucil, hexamethylphosphamide, bisulfan, and the like. Mutation-inducing agents by irradiation include ultraviolet irradiation, γ-irradiation, x-rays, and fast neutron bombardment. Also, genetic variations can be introduced into nucleic acids, for example, using trimethylpsoralen with ultraviolet irradiation. Another suitable method for generating genetic variation is the random or targeted insertion of a transposable DNA element, such as a transposon. Genetic variations can be introduced into the nucleic acid by amplification in an in vitro cell-free system, for example, using a polymerase chain reaction (PCR) method, such as reduced fidelity PCR. Genetic variations can be introduced into nucleic acids in vitro using DNA shuffling techniques (eg, exon shuffling, domain swaps, and the like). Genetic variations can also be introduced into nucleic acids as a result of a lack of DNA repair enzymes in the cell, for example, it is believed that the presence in the cell of a mutant gene encoding a mutant DNA repair enzyme will result in a high mutation rate (i.e., from about 1 mutation /100 genes to 1 mutation/10,000 genes) in the cell genome. Non-limiting examples of genes encoding DNA repair enzymes include Mut H, Mut S, Mut L, and Mut U and their homologues in other species (e.g., MSH1 to MSH6, PMS1 to PMS2, MLH1, GTBP, ERCC-1 etc.). Examples of descriptions of various methods for introducing genetic variation are given, for example, in Stemple (2004) Nature 5:1-7; Chiang et al. (1993) PCR Methods Appl 2(3): 210-217; Stemmer (1994) Proc. Natl. Acad. sci. USA 91:10747-10751 and US Pat. Nos. 6,033,861 and 6,773,900.

[0106] As a method of cyclic amplification in polymerase chain reaction (PCR) mutagenesis, mutagenic primers are used to introduce desired mutations. PCR is carried out in the form of cycles of denaturation, annealing and completion. After PCR amplification, selection of mutant DNA and removal of the original plasmid DNA can be done by: 1) replacing dCTP during PCR with hydroxymethylated dCTP, followed by restriction enzyme digestion to remove only the non-hydroxymethylated original DNA; 2) simultaneous mutagenesis of the antibiotic resistance gene and the gene of interest, changing the antibiotic resistance of the plasmid to resistance to other antibiotics, where resistance to new antibiotics then facilitates the selection of the desired mutation; 3) cleavage of the original methylated template DNA after introducing the desired mutation with the restriction enzyme DpnI, which cleaves only methylated DNA, whereby the mutant unmethylated strands are isolated; or 4) obtaining circular molecules of mutant PCR products in an additional ligation reaction with an increase in the efficiency of transformation of the mutant DNA. Additional description of illustrative methods can be found, for example, in US7132265, US6713285, US6673610, US6391548, US5789166, US5780270, US5354670, US5071743 and US20100267147.

[0107] Oligonucleotide-specific mutagenesis, also referred to as site-specific mutagenesis, typically uses a synthetic DNA primer. This synthetic primer contains the desired mutation and is complementary to the template DNA around the site of the mutation so that it can hybridize to the DNA in the gene of interest. The mutation may be a single nucleotide substitution (point mutation), a multi-nucleotide substitution, a deletion or insertion, or a combination thereof. The single strand primer is then completed using a DNA polymerase that copies the rest of the gene. The gene copied in this manner contains a mutated region and can then be introduced into a host cell as a vector and cloned. Finally, mutants can be selected by DNA sequencing to verify that they contain the desired mutation.

[0108] Genetic variations can be introduced using PCR with reduced accuracy. In this method, a gene of interest is amplified using a DNA polymerase under conditions of insufficient sequence replication fidelity. The result is that the amplification products contain at least one sequence error. When a gene is amplified and the resulting reaction product(s) contains one or more sequence changes from the template molecule, the resulting products are mutated from the template. Another way to introduce random mutations is to expose the cells to a chemical mutagen such as nitrosoguanidine or ethylmethanesulfonate (Nestmann, Mutat Res 1975 June; 28(3):323-30) and then isolate the vector containing the gene from the host.

[0109] Another method of random mutagenesis is saturation mutagenesis, which tries to get all or almost all possible mutations in a particular region or small region of a gene. In a broad sense, saturation mutagenesis consists of mutagenesis of a complete set of mutagenic cassettes (where each cassette is, for example, 1-500 bases long) in a specific mutagenesis polynucleotide sequence (where the mutagenesis sequence is, for example, 15 to 100,000 bases long). Thus, a group of mutations (eg, ranging from 1 to 100 mutations) is introduced into each cassette to be mutated. The group of mutations introduced into one cassette may be different or the same as the second group of mutations introduced into the second cassette during one round of saturation mutagenesis. Examples of such groups are deletions, additions, specific codon groups, and specific nucleotide cassette groups.

[0110] Fragment shuffling mutagenesis, also referred to as DNA shuffling, is a way to rapidly reproduce favorable mutations. In an exemplary shuffling method, DNase is used to fragment a set of original genes into pieces of length, eg, approximately 50-100 bp. After that, a polymerase chain reaction (PCR) is carried out without primers - DNA fragments with sufficient overlap of homologous sequences are annealed to each other and then they are completed by DNA polymerase. After some DNA molecules reach the size of the original genes, several cycles of this completion are carried out by PCR. These genes can then be amplified by another PCR, this time with the addition of primers designed to be complementary to the ends of the chains. The primers may have additional sequences added to their 5' ends, such as restriction enzyme recognition sequences required for ligation into a cloning vector. Additional examples of permutation methods are given in US20050266541.

[0111] Mutagenesis by homologous recombination involves the recombination of an exogenous DNA fragment and a target polynucleotide sequence. After the formation of double-strand breaks, the sections of DNA at the 5' ends of the breaks are removed in a process called resection. In a subsequent strand insertion step, the 3' protruding end of the broken DNA molecule is then "introduced" into a similar or identical DNA molecule that has not been broken. The method can be used to remove genes, remove exons, add genes, and introduce point mutations. Mutagenesis by homologous recombination may be permanent or conditional. Typically, a recombination matrix is also provided. The recombination template may be a component of another vector contained in a separate vector or provided as a separate polynucleotide. In certain embodiments, the recombination template is designed to serve as a template in homologous recombination, for example, within or adjacent to the target sequence being cut or cleaved by the site-specific nuclease. The length of the template polynucleotide may be any suitable length, for example, the length may be about or more than about 10, 15, 20, 25, 50, 75, 100, 150, 200, 500, 1000 or more nucleotides. In certain embodiments, the template polynucleotide is complementary to the portion of the polynucleotide containing the target sequence. When optimally aligned, the template polynucleotide may overlap with one or more nucleotides of the target sequence (e.g., about or more than about 1, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100 or more nucleotides). In certain embodiments, when the template sequence and the polynucleotide containing the target sequence are optimally aligned, the nearest nucleotide of the template polynucleotide is within about 1, 5, 10, 15, 20, 25, 50, 75, 100, 200, 300, 400 , 500, 1000, 5000, 10000 or more nucleotides from the target sequence. Non-limiting examples of site-specific nucleases useful in homologous recombination methods include zinc finger nucleases, CRISPR nucleases, TALE nucleases, and meganuclease. For further descriptions of the use of such nucleases, see, for example, US8795965 and US20140301990.

[0112] CRISPR/Cas9 (regularly arranged short palindromic repeats)/CRISPR-associated (Cas) systems provide bacteria and archaea with acquired immunity against viruses and plasmids through the use of CRISPR RNA (cpRNA), directing the silencing of invading nucleic acids. The Cas9 protein (or its functional equivalent and/or variant, i.e., a Cas9-like protein) naturally has DNA endonuclease activity that depends on the association of the protein with two natural or synthetic RNA molecules called cpRNA and transcpRNA (also called guide RNA). In some cases, two molecules are covalently linked to form a single molecule (also referred to as a single guide RNA ("sRNA"). Thus, a Cas9 protein or a Cas9-like protein associates with a DNA-directed RNA (where this term includes a two-guide RNA configuration). and single guide RNA configuration) that activates Cas9 or a Cas9-like protein and directs the protein to a target nucleic acid sequence. If Cas9 or a Cas9-like protein retains its enzymatic function, it cleaves the target DNA to form a double-strand break, which can to modify the genome (i.e., edit: deletions, insertions (when a donor polynucleotide is present), substitution, etc.), thereby altering gene expression. Certain variants of Cas9 (which are included in the term Cas9-like) alter so so that they have reduced DNA cleavage activity (in some cases they cleave one strand instead of both strands of DNA -target, while in other cases their activity is greatly reduced to the absence of DNA cleavage activity). Additional illustrative descriptions of CRISPR systems for introducing genetic variation can be found in, for example, US8795965.

[0113] To obtain genetic variations, mutagens can be used, by which point mutations and short deletions, insertions, transversions and/or transitions are predominantly obtained, including chemical mutagens or irradiation. Non-limiting examples of mutagens include ethyl methanesulfonate, methyl methanesulfonate, N-ethyl-N-nitrosourea, triethylmelamine, N-methyl-N-nitrosourea, procarbazine, chlorambucil, cyclophosphamide, diethyl sulfate, monomeric acrylamide, melphalan, nitrogen mustard, vincristine, dimethylnitrosamine, N- methyl-N'-nitronitrosoguanidine, nitrosoguanidine, 2-aminopurine, 7,12-dimethylbenz(a)anthracene, ethylene oxide, hexamethylphosphamide, bisulfan, diepoxyalkanes (diepoxyoctane, diepoxybutane, etc.), 2-methoxy-6-chloro-dihydrochloride 9[3-(ethyl-2-chloroethyl)aminopropylamino]acridine and formaldehyde.

[0114] The introduction of genetic variation may be a work in progress such that certain bacteria in the treated bacterial population carry the desired mutation while others do not. In certain cases, selection pressure must be applied to enrich for bacteria carrying the desired genetic variation. Generally, selection of successful genetic variants involves selection for or against a particular functionality conferred or removed by the genetic variation, such as insertion of an antibiotic resistance gene or removal of a metabolic activity that allows the conversion of a non-lethal compound to a lethal metabolite. Also, selection pressure can be applied on the basis of the polynucleotide sequence itself, such that only the desired genetic variation needs to be introduced (eg also without the need for a selectable marker). In this case, the selection pressure may include cleavage of genomes with no genetic variation introduced into the target site, such that selection is effectively directed against a reference sequence into which the genetic variation is to be introduced. Typically, cleavage occurs within 100 nucleotides of the target site (eg, within 75, 50, 25, 10 or less nucleotides of the target site, including cleavage at or within the target site). Cleavage can be directed by a site-specific nuclease selected from the group consisting of zinc finger nuclease, CRISPR nuclease, TALE nuclease (TALEN), or meganuclease. Such a process is similar to the processes for increasing homologous recombination at the target site, except that no template for homologous recombination is provided. As a result, bacteria without the required genetic variation are more likely to undergo cleavage, which in the absence of repair leads to cell death. The bacteria surviving the selection can then be isolated for use in plant treatment to assess the improved trait imparted.

[0115] CRISPR nuclease can be used to direct the cleavage at the target site. By using Cas9 to kill wild-type cells, improved selection of mutant microorganisms can be achieved. The plants are then inoculated with mutant microorganisms to confirm the symbiosis and provide evolutionary pressure to select effective symbionts. The microorganisms can then be re-isolated from plant tissues. In systems with CRISPR nucleases used to select for the absence of variants, elements similar to those described above regarding the introduction of genetic variation elements can be used, except that they do not provide a template for homologous recombination. Thus, cleavage directed to the target site increases the death of exposed cells.

[0116] Other variants of specifically induced cleavage at the target site are available, such as zinc finger nucleases, TALE nuclease (TALEN) systems, and meganuclease. Zinc finger nucleases (ZFNs) are artificial DNA endonucleases obtained by fusing the DNA-binding domain of zinc fingers with a DNA cleavage domain. ZFNs can be designed to cleave desired DNA sequences and this allows zinc finger nucleases to cleave unique target sequences. When introduced into a cell, ZFN can be used to edit a target DNA in the cell (eg, the cell's genome) by inducing double-strand breaks. Transcription activator-like effector nucleases (TALEN) are artificial DNA endonucleases obtained by fusing the effector DNA-binding domain of TAL (like transcription activators) to a DNA cleavage domain. TALEN can be quickly designed to bind virtually any desired DNA sequence, and when introduced into a cell, TALEN can be used to edit a target DNA in a cell (eg, the cell's genome) by introducing double-strand breaks. Meganucleases (homing endonucleases) are endodeoxyribonucleases characterized by a large recognition site (double-stranded DNA sequences ranging in length from 12 to 40 base pairs). Meganucleases can be used to replace, delete or modify sequences in a narrow manner. By modifying the sequences they recognize through protein engineering, the target sequence can be changed. Meganucleases can be used to modify all types of genomes, bacteria, plants or animals, and are generally grouped into four families: the LAGLIDADG family, the GIY-YIG family, the His-Cyst box family, and the HNH family. Exemplary homing endonucleases include I-SceI, I-CeuI, PI-PspI, PI-Sce, I-SceIV, I-CsmI, I-PanI, I-SceII, I-PpoI, I-SceIII, I-CreI, I -TevI, I-TevII and I-TevIII.

[0117] The methods of the present invention can be used to impart or improve one or more of a number of desired features. Examples of traits that can be given or improved include: root biomass, root length, growth, shoot height, number of leaves, water use efficiency, total biomass, yield, fruit size, seed size, photosynthesis rate, drought tolerance, heat tolerance, salt tolerance, tolerance to nematode stress, fungal pathogen resistance, bacterial pathogen resistance, viral pathogen resistance, metabolite level and proteome expression. Required traits including growth, total biomass, root and/or shoot biomass, seed germination, seedling viability, photosynthetic efficiency, transcription rate, seed/fruit number or weight, plant seed or fruit yield, leaf chlorophyll content, photosynthesis rate, length roots, or any combination thereof, can be used to determine growth and compare with the growth rate of reference crop plants (eg, plants without improved traits) grown under identical conditions. The preferred attribute to be imparted or improved, as described herein, is nitrogen fixation. In some instances, plants produced by the methods described herein exhibit trait differences that are at least about 5%, such as at least about 5%, at least about 8%, over at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 75%, at least about 80%, at least about 80%, at least about 90%, or at least 100%, at least about 200%, at least about 300%, at least about 400% or more compared to a reference crop grown in soil in the same terms.

[0118] An improved trait can be assessed under conditions involving exposure to one or more biotic or abiotic stressors. Examples of stressors include abiotic stressors (such as heat stress, salt stress, drought stress, cold stress, and nutrient deficiency stress) and biotic stressors (such as nematode stress, herbivorous insect stress, stress, stress caused by fungal pathogens, stress caused by bacterial pathogens and stress caused by viral pathogens).

[0119] The trait improved by the methods and compositions of the present invention may be nitrogen fixation, including in a plant previously incapable of nitrogen fixation. In some cases, bacteria isolated by the method described herein produce 1% or more (for example, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15% , 20% or more) of plant nitrogen, which may represent an increase in nitrogen fixation capacity of at least 2-fold (e.g., 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold , 9-fold, 10-fold, 20-fold, 50-fold, 100-fold, 1000-fold or more) compared to bacteria isolated from the first plant before any genetic variation was introduced. In some cases, the bacteria produce 5% or more of the plant's nitrogen. The desired level of nitrogen fixation can be achieved after repeating the steps of introducing genetic variation, exposing multiple plants, and isolating bacteria from trait-improved plants (e.g., 1, 2, 3, 4, 5, 10, 15, 25, or more times) once or multiple times. . In some cases, increased levels of nitrogen fixation are achieved in the presence of a fertilizer supplemented with glutamine, ammonia, or other chemical nitrogen source. Known methods for assessing the degree of nitrogen fixation, examples of which are described in this document.

Nitrogen fixation

[0120] Described herein are methods of increasing nitrogen fixation in a plant, comprising exposing the plant to bacteria carrying one or more genetic variations introduced into one or more genes that regulate nitrogen fixation, where the bacteria produce 1% or more nitrogen in the plant (e.g. , 2%, 5%, 10% or more), which may represent at least 2 times the nitrogen fixation capacity compared to the plant in the absence of bacteria. Bacteria can produce nitrogen in the presence of a fertilizer supplemented with glutamine or ammonia. Genetic variations can be any of the genetic variations described herein, including the examples above, in any amount and in any combination. Genetic variation can be introduced into a gene selected from the group consisting of nifA, nifL, ntrB, ntrC, glutamine synthetase, glnA, glnB, glnK, draT, amtB, glutaminase, glnD, glnE, nifJ, nifH, nifD, nifK, nifY, nifE , nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ. The genetic variation may be a mutation that results in one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity. A genetic variation introduced into one or more bacteria by the methods described herein may be a knockout mutation, or it may remove the regulatory sequence of the target gene, or it may include the insertion of a heterologous regulatory sequence, for example, the insertion of a regulatory sequence identified in bacterial genome of the same species or genus. The regulatory sequence can be selected based on the level of expression of the gene in the bacterial culture or plant tissue. Genetic variation can be obtained by chemical mutagenesis. Plants grown in step (c) may be subjected to biotic or abiotic stress factors.

[0121] Nitrogen fixation occurring in the plants described herein can be quantified in a variety of ways, for example, through an acetylene reduction (AR) assay. The acetylene reduction assay can be performed in vitro or in vivo . Evidence that a particular bacterium provides fixed nitrogen to the plant may include: 1) the total N of the plant significantly increases after inoculation, preferably with a concomitant increase in N concentration in the plant; 2) symptoms of nitrogen deficiency under N-limiting conditions improve after inoculation (which should include an increase in dry weight); 3) documentation of N ₂ fixation using the ¹⁵ N approach (which may be isotope dilution experiments, ¹⁵ N ₂ recovery assays, or natural ¹⁵ N abundance assays); 4) the incorporation of fixed N into the plant protein or metabolite; and 5) the absence of all these effects in plants without inoculation or in plants inoculated with a mutant of the inoculated strain.

[0122] The wild-type nitrogen fixation regulatory cascade can be thought of as a digital logic circuit where incoming O ₂ and NH ₄ ⁺ are passed through a NOR logic gate whose output, in addition to ATP, goes to an AND logic gate. In certain embodiments, the methods, described here disrupt the action of NH ₄ ⁺ on this circuit at several points in the regulatory cascade so that microorganisms can produce nitrogen even in fertilized fields. However, the methods described herein also involve altering the effect of ATP or O ₂ on the schema, or altering the schema using other regulatory cascades in the cell, or altering genetic circuits other than nitrogen fixation. It is possible to rearrange gene clusters to obtain functional products under the control of a heterologous regulatory system. By removing natural regulatory elements outside and in the coding sequences of gene clusters and replacing them with alternative regulatory systems, the functional products of complex genetic operons and other gene clusters can be controlled and/or placed in heterologous cells, including cells of other species than those from which the natural genes. Once rearranged, the synthetic gene clusters can be controlled by genetic circuits or other inducible regulatory systems, thus controlling the expression of the products as desired. Expression cassettes can be designed to act as logic gates, pulse generators, oscillators, switches, or memory devices. The control expression cassette can be ligated to the promoter such that the expression cassette functions as an environmental sensor, such as an oxygen, temperature, touch, osmotic stress, surface tension, or redox sensor.

[0123] As an example, the nifL, nifA, nifT, and nifX genes can be deleted from the nif gene cluster. Synthetic genes can be constructed by randomizing the codons of the DNA encoding each amino acid sequence. The selection of codons is carried out by establishing that the frequency of use of codons is as different as possible from the frequency of use of codons in the natural gene. The proposed sequences are scanned for any undesirable features such as restriction enzyme recognition sites, transposon recognition sites, repeat sequences, sigma 54 and sigma 70 promoters, cryptic ribosome binding sites, and rho-independent terminators. Synthetic ribosome binding sites are chosen to match the strength of each corresponding natural ribosome binding site, for example by constructing a fluorescent reporter plasmid in which the 150 bp surrounding the gene's start codon (-60 to +90) is fused to the gene fluorescent marker. This chimeric gene can be expressed under the control of the Ptac promoter and fluorescence measured by flow cytometry. To obtain synthetic ribosome binding sites, a reporter plasmid library is prepared using 150 bp. (-60 to +90) synthetic expression cassette. Briefly, a synthetic expression cassette may consist of a random DNA spacer, a degenerate sequence encoding an RBS library, and the coding sequence for each synthetic gene. Multiple clones are screened to identify a synthetic ribosome binding site that best matches the natural ribosome binding site. Thus, synthetic operons are constructed that consist of the same genes as natural operons and tested for functional complementation. An additional illustrative description of synthetic operons is given in US20140329326.

Types of bacteria

[0124] Microorganisms useful in the methods and compositions described herein can be obtained by isolating microorganisms from the surfaces or tissues of natural plants; crushing seeds with the release of microorganisms; planting seeds in various soil samples and isolating microorganisms from tissues; or inoculating plants with exogenous microorganisms and determining which microorganisms are found in plant tissues. Non-limiting examples of plant tissues include seeds, shoots, leaves, sections, plants, bulbs, or tubers. In some cases, bacteria are isolated from seeds. Sample processing parameters can be varied to isolate different types of associated microorganisms such as rhizosphere microorganisms, epiphytes or endophytes. Instead of initial isolation from the first plant, the bacteria can also be obtained from repositories such as collections of natural strains. Microorganisms can be genotyped and phenotyped by sequencing the genomes of isolated microorganisms; profiling the composition of communities in planta ; characteristics of the functionality of transcriptomes of communities or isolated microorganisms; or screening for microbial properties using selective or phenotypic media (eg, nitrogen-fixing or phosphate-dissolving phenotypes). Selected strains or candidate populations can be derived from sequencing data; phenotyping data; plant data (eg genome, phenotype and/or yield data); soil data (eg, pH, N/P/K content, and/or biotic community of the base soil), or any combination of these.

[0125] The bacteria and methods for producing bacteria described herein can be used for bacteria capable of efficient self-propagation on leaf surfaces, root surfaces, or within plant tissues without inducing a destructive plant defense response, or for bacteria that are resistant to defense plant reactions. The bacteria described herein can be isolated by culturing a plant tissue extract or by washing the leaf surface in a medium without the addition of nitrogen. However, the bacteria may be non-culturable, ie. their culturability may not be known, or they may be difficult to cultivate by standard methods known in the art. The bacteria described herein may be endophytic or epiphytic, or bacteria living in the rhizosphere of a plant (rhizosphere bacteria). Bacteria obtained after repeating the steps of introducing genetic variation, exposing multiple plants, and isolating bacteria from plants with an improved trait (e.g., 1, 2, 3, 4, 5, 10, 15, 25, or more times) may be endophytic , epiphytic or rhizospheric. Endophytes are organisms that enter the interior of plants without causing disease symptoms or causing the formation of symbiotic structures, and are of agronomic interest because they can enhance plant growth and improve plant nutrition (eg, through nitrogen fixation). The bacteria may be seed-borne endophytes. Seed-borne endophytes include bacteria associated with or derived from seeds of grasses or other plants, such as seed-borne bacterial endophytes found in mature, dry, undamaged (e.g., no cracks, no visible fungal infection, or no premature germination) seeds . Seed-borne bacterial endophytes may be associated or obtained from the surface of seeds; alternatively, or in addition, they may be associated or may be obtained from the internal compartment of the seed (eg surface-sterilized seeds). In certain cases, seed-borne bacterial endophytes are able to replicate in plant tissues, for example, within seeds. In certain cases, seed-borne bacterial endophytes are also able to survive dehydration.

[0126] Bacteria isolated by the methods of the invention may include a variety of bacteria of different taxa in combination. By way of example, bacteria may include Proteobacteria (such as Pseudomonas, Enterobacter, Stenotrophomonas, Burkholderia, Rhizobium, Herbaspirillum, Pantoea, Serratia, Rahnella, Azospirillum, Azorhizobium, Azotobacter, Duganella, Delftia, Bradyrhizobiun, Sinorhizobium and Halomonas) , Firmicutes (such as Bacillus , Paenibacillus, Lactobacillus, Mycoplasma and Acetabacterium) and Actinobacteria (such as Streptomyces, Rhodacoccus, Microbacterium and Curtobacterium) . Bacteria obtainable by the methods described herein include Azotobacter spp., Bradyrhizobium spp., Klebsiella spp. and Sinorhizobium spp . The bacteria can be selected from the group consisting of: Azotobacter vinelandii, Bradyrhizobium japonicum, Klebsiella pneumoniae and Sinorhizobium meliloti . The bacteria may be of the genera Enterobacter and Rahnella .

[0127] Bacteria can be obtained from any common terrestrial environment, including its soils, plants, fungi, animals (including invertebrates), and other biota, including sediment, water, and biota of lakes and rivers; from the marine environment, its biota and sediments (eg sea water, sea silt, marine plants, marine invertebrates (eg sponges), marine vertebrates (eg fish)); terrestrial and marine geosphere (loose surface sediments and stones, for example, crushed subsoil stones, sand and clays); the cryosphere and its melt waters; atmosphere (for example, filtered suspended dust, cloud and rain drops); urban, industrial, and other man-made environments (eg, accumulated organic and mineral material on concrete, curbs, roof surfaces, and road surfaces).

[0128] The plants from which the bacteria are obtained can be a plant with one or more of the desired traits, such as plants that naturally grow in a particular environment or under certain conditions of interest. As an example, a certain plant may naturally grow in sandy soil or sand with a high mineral content, or at extreme temperatures, or with little water, or it may be resistant to certain pests or diseases present in the environment, and it may be desirable growing a commercial crop under such conditions, in particular, for example, if they are the only conditions available in a particular geographical location. As a further example, the bacteria can be isolated from a commercial crop grown in such media, or more specifically, from a particular crop in which, among crops grown in any particular environment, the trait of interest is best represented: for example, fastest growing plants among crops grown in soils with limited salt levels, or the least damaged plants among crops that have been severely damaged by insects or epidemic disease, or plants with the required amounts of certain metabolites and other compounds, including fiber content, oil content, etc. , or plants that exhibit the required colors, tastes or smells. Bacteria can be isolated from the plant of interest or any material found in the environment of interest, including fungi and other animal and plant biota, soil, water, sediment, and other environmental components, as previously noted.

[0129] Bacteria can be isolated from plant tissue. This isolation can be carried out from any suitable tissue of the plant, including, for example, the root, stem and leaves, and reproductive tissues of the plant. By way of example, conventional plant isolation methods typically involve sterile cutting of test plant material (e.g., root or stem sections, leaves), surface sterilization with a suitable solution (e.g., 2% sodium hypochlorite), and then placing the plant material on nutrient medium for the growth of microorganisms. Alternatively, the surface-sterilized plant material can be ground into a sterile liquid (typically water) and a liquid suspension containing small portions of the ground plant material applied to the surface of a suitable solid agarose medium or media, which may or may not be selective (e.g., contain only phytic acid). acid as a source of phosphorus). This approach is particularly useful for bacteria that form isolated colonies and that can be individually transferred to separate culture media plates and further purified to a single species by well-known methods. Alternatively, samples of the roots or leaves of the plant may not be surface-sterilized, but only gently washed, thus including surface-dwelling epiphytic microorganisms in the isolation process, or epiphytic microorganisms can be isolated separately by applying and removing parts of the roots, stems or leaves of plants on the surface. agarose medium and then isolating individual colonies as described above. This approach is particularly suitable, for example, for bacteria. Alternatively, the roots can be treated without washing off the small amounts of soil adhering to the roots, thus including the microorganisms that colonize the plant's rhizosphere. In other cases, the soil adhering to the roots can be taken, diluted and applied to agar with suitable selective and non-selective media to obtain individual colonies of rhizospheric bacteria.

[0130] Biologically pure cultures of Rahnella aquatilis and Enterobacter sacchari were deposited on July 14, 2015 with the American Type Culture Collection (ATCC; International Depositary Authority), Manassas, VA, USA, and assigned ATTC patent deposit reference numbers PTA-122293 and PTA-122294 , respectively. These deposits are made in accordance with the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purpose of Patent Procedure and the Regulations (Budapest Treaty).

Compositions

[0131] Compositions containing bacteria or bacterial populations produced by the methods described herein and/or with characteristics as described herein can also be used to improve plant traits. Compositions containing bacterial populations can be applied to the surface of seeds and can be in liquid form. The compositions include seed coatings for commercially important crops such as sorghum, canola, tomato, strawberry, barley, rice, corn and wheat. The compositions can also be sprayed onto the aerial parts of the plants or applied to the roots by placing them in the furrows in which the plant seeds are planted, watering the soil or dipping the roots into a suspension of the composition. The compositions can be dehydrated in a suitable manner which preserves cell viability and the ability to artificially populate and colonize host plants. The bacterial species may be present in the compositions at a concentration of from 10 ⁸ to 10 ¹⁰ cfu/ml. The compositions can be supplemented with trace metal ions such as molybdenum ions, iron ions, manganese ions, or combinations of these ions. Ion concentrations in the compositions described herein can be from about 0.1 mM to about 50 mM. The compositions can also be formulated with a carrier such as beta-glucan, carboxymethylcellulose (CMC), bacterial extracellular polymeric substance (EPS), sugar, animal milk, or other suitable carriers. Alternatively, peat or planting materials or biopolymers can be used as a carrier, in which the composition is placed in a biopolymer. Compositions containing the bacterial populations described herein can improve plant traits, such as promoting plant growth, maintaining high leaf chlorophyll content, increasing fruit or seed numbers, and increasing single fruit or seed weight.

[0132] Compositions containing the bacterial populations described herein can be applied to the surface of seeds. Thus, compositions are contemplated containing seeds coated with one or more of the bacterial species described herein. The seed coat can be formulated by mixing a population of bacteria with a porous, chemically inert granular carrier. Alternatively, the compositions can be applied directly to the furrows in which the seeds are planted, or sprayed onto the leaves of the plants, or applied by dipping the roots into the suspension of the composition. An effective amount of the composition can be used to fill an area of soil near the roots of a plant with growth of viable bacteria, or to colonize the leaves of a plant with growth of viable bacteria. Generally, an effective amount is an amount sufficient to produce plants with improved traits (eg, the desired level of nitrogen fixation).

[0133] The bacterial compositions described herein can be formulated using an agriculturally acceptable carrier. A formulation suitable for these embodiments may contain at least one member selected from the group consisting of tackifying agent, microorganism stabilizer, fungicide, antibacterial agent, herbicide, nematicide, insecticide, plant growth regulator, fertilizer, rodenticide, moisture scavenger and nutrient. For example, any of the compositions described herein may contain an agriculturally acceptable carrier (e.g., one or more of fertilizers, such as a non-natural fertilizer, tackifiers, such as a non-natural tackifier, and pesticides, such as a non-natural pesticide ). The non-natural tackifier may be, for example, a polymer, copolymer or synthetic wax. For example, any of the coated seeds, seedlings or plants described herein may contain such an agriculturally acceptable carrier in the seed coating. In any of the compositions or methods described herein, the agriculturally acceptable carrier may be or may contain a non-natural compound (eg, a non-natural fertilizer, a non-natural tackifier such as a polymer, copolymer, or synthetic wax, or a non-natural pesticide). Non-limiting examples of agriculturally acceptable carriers are described below. Additional examples of agriculturally acceptable carriers are known in the art.

[0134] In some cases, the bacteria are mixed with an agriculturally acceptable carrier. The carrier may be a solid carrier or a liquid carrier, and may be in various forms, including microspheres, powders, emulsions, and the like. The carrier may be any one or more of a number of carriers that provide a number of properties such as increased stability, wettability, or dispersibility. The compositions may include wetting agents such as natural or synthetic surfactants, which may be non-ionic or ionic surfactants, or a combination thereof. Also, water-in-oil emulsions can be used to formulate compositions that contain isolated bacteria (see, for example, US Pat. No. 7,485,451). Suitable formulations that can be prepared include wettable powders, granules, gels, agarose plates or beads, thickeners and the like, microencapsulated particles and the like, liquids such as aqueous liquids, aqueous suspensions, water-in- oil, etc. The composition may contain grains or legumes, for example, ground grains or beans, broth or fine flour obtained from grains or beans, starch, sugar or oil.

[0135] In certain embodiments, the implementation of the agricultural carrier may be a soil or environment for growing plants. Other agricultural vehicles that can be used include water, fertilizers, vegetable oils, humectants, or combinations thereof. Alternatively, the agricultural carrier may be a solid such as diatomaceous earth, clay, silica, alginate, clay soil, bentonite, vermiculite, seed pods, other plant and animal products, or combinations thereof, including granules, sludge, or suspensions. Mixtures of any of the above ingredients are also contemplated as non-limiting examples, such as pestle (fine flour and kaolin clay), agar balls or fine flour in clay, sand or clay soil, etc. The formulations may contain food sources for bacteria such as barley, rice, or other biological materials such as seeds, plant parts, sugar cane pomace, grain husks or stalks, shredded plant material or wood from construction site waste, sawdust, or fine fibers. after processing paper, fabric or wood.

[0136] For example, a fertilizer can be used to help promote growth or provide nutrients to seeds, seedlings, or plants. Non-limiting examples of fertilizers include nitrogen, phosphorus, potassium, calcium, sulfur, magnesium, boron, chloride, manganese, iron, zinc, copper, molybdenum, and selenium (or salts thereof). Additional examples of fertilizers include one or more amino acids, salts, carbohydrates, vitamins, glucose, NaCl, yeast extract, NH ₄ H ₂ PO ₄ , (NH ₄ ) ₂ SO ₄ , glycerol, valine, L-leucine, lactic acid, propionic acid, succinic acid, malic acid, citric acid, KH tartrate, xylose, lyxose and lecithin. In one embodiment, the formulation may contain a tackifier or adhesive (referred to as an adhesive) to help bind other active agents to the substance (eg, the surface of the seeds). Such agents are suitable for combining bacteria with carriers which may contain other compounds (eg control agents which are non-biological) to form a coating composition. Such compositions help to provide coatings around a plant or seed while maintaining contact of microorganisms and other agents with the plant or plant part. In one embodiment, the adhesives are selected from the group consisting of: alginate, gums, various starches, lecithins, formononetin, polyvinyl alcohol, alkaline formononetinate, hesperetin, polyvinyl acetate, cephalins, gum arabic, xanthan gum, mineral oil, polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), arabino-galactan, methylcellulose, PEG 400, chitosan, polyacrylamide, polyacrylate, aoliacrylonitrile, glycerin, triethylene glycol, vinyl acetate, gellan gum, polystyrene, polyvinyl, carboxymethyl cellulose, ghatti gum and polyoxyethylene-polyoxybutylene block copolymers.

[0137] In certain embodiments, the adhesives may be, for example, a wax such as carnauba wax, beeswax, Chinese wax, shellac wax, spermaceti wax, candelilla wax, hydrogenated castor oil, oricuria wax, and rice bran wax, a polysaccharide (e.g. , starch, dextrins, maltodextrins, alginate and chitosans), fat, oil, protein (eg gelatin and zeins), gum arabic and shellacs. Adhesives may be non-natural compounds such as polymers, copolymers and waxes. For example, non-limiting examples of polymers that can be used as an adhesive include: polyvinyl acetates, polyvinyl acetate copolymers, ethylene-vinyl acetate (EVA) copolymers, polyvinyl alcohols, polyvinyl alcohol copolymers, cellulose compounds (e.g. various types of ethylcellulose, methylcellulose, hydroxymethylcellulose, hydroxypropylcellulose and carboxymethylcelluloses), polyvinylpyrrolidones, vinyl chloride, vinylidene chloride copolymers, calcium lignosulfonates, acrylic copolymers, polyvinyl acrylates, polyethylene oxide, acylamide polymers and copolymers, polyhydroxyethyl acrylate, monomeric methylacrylamides and polychloroprene.

[0138] In certain examples, one or more of the adhesives, antifungals, growth regulators, and pesticides (eg, insecticides) are non-natural compounds (eg, in any combination). Additional examples of agriculturally acceptable carriers include dispersants (eg, polyvinylpyrrolidone/vinyl acetate PVPIVA S-630), surfactants, binders, and fillers.

[0139] The composition may also contain a surfactant. Non-limiting examples of surfactants include mixtures of nitrogen fertilizers and surfactants such as Prefer 28 (Cenex), Surf-N (US), Inhance (Brandt), P-28 (Wilfarm) and Patrol (Helena); esterified seed oils include Sun-It II (AmCy), MSO (UAP), Scoil (Agsco), Hasten (Wilfarm) and Mes-100 (Drexel); and organo-silicone surfactants include Silwet L77 (UAP), Silikin (Terra), Dyne-Amic (Helena), Kinetic (Helena), Sylgard 309 (Wilbur-Ellis) and Century (Precision). In one embodiment, the surfactant is present at a concentration of 0.01% v/v. up to 10% v/v In another embodiment, the surfactant is present at a concentration of 0.1% v/v. up to 1% v/v

[0140] In certain cases, the composition contains a microorganism stabilizer. Such agent may include a desiccant, which may include any compound or mixture of compounds that can be classified as a desiccant, whether or not the compound or compounds are used at such concentrations that they actually exhibit a drying effect on the liquid inoculating agent. Such desiccants are ideally compatible with the bacterial populations used and should maintain the ability of the microbial population to survive seed application and survive dehydration. Examples of suitable moisture scavengers include one or more of trehalose, sucrose, glycerol and methylene glycol. Other suitable moisture scavengers include non-limiting examples of non-reducing sugars and sugar alcohols (eg mannitol or sorbitol). The amount of desiccant incorporated into the formulation may range from about 5% to about 50% by weight/volume, for example, from about 10% to about 40%, from about 15% to about 35%, or from about 20% to approximately 30%. In some instances, it is preferred that the formulation contains agents such as a fungicide, antibacterial agent, herbicide, nematocide, insecticide, plant growth regulator, rodenticide, or nutrient. Non-limiting examples of growth regulators include brassinosteroids, cytokinins (eg, kinetin and zeatin), auxins (eg, indoleacetic acid and indole acetylaspartate), flavonoids and isoflavonoids (eg, formononetin and diosmetin), phytoauxins (eg, glyceollin), and phytoalexin-inducible oligosaccharides (eg, pectin, chitin, chitosan, polygalacturonic acid and oligogalacturonic acid) and gibellerins. Such agents are ideally compatible with the agricultural seed or seedling to which the composition is applied (eg, it must not be harmful to plant growth or health). In addition, ideally, the agent is an agent that does not pose a safety hazard to human, animal, or industrial use (e.g., no safety hazards, or the compound is sufficiently unstable such that a consumable herbal product derived from the plant contains negligible amounts of it). connections).

[0141] In liquid form, for example, in solution or suspension, bacterial populations can be mixed or suspended in water or in aqueous solutions. Suitable liquid diluents or carriers include water, aqueous solutions, petroleum distillates or other liquid carriers.

[0142] Solid compositions can be prepared by dispersing bacterial populations in and on a suitably pulverized solid carrier such as peat, wheat, bran, vermiculite, clay, talc, bentonite, diatomaceous earth, fuller's clay, pasteurized soil, and the like. When such formulations are used as wettable powders, biocompatible dispersants such as non-ionic, anionic, amphoteric or cationic dispersants and emulsifiers can be used.

[0143] Solid carriers used in the formulation include, for example, mineral carriers such as kaolin clay, pyrophyllite, bentonite, montmorillonite, diatomaceous earth, acid white earth, vermiculite, and perlite, and inorganic salts such as ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride and calcium carbonate. Organic fine powders such as wheat flour, wheat bran and rice bran can also be used. Liquid carriers include vegetable oils such as soybean oil and cottonseed oil, glycerin, ethylene glycol, polyethylene glycol, propylene glycol, polypropylene glycol, and the like.

plant species

[0144] The methods and bacteria described herein are suitable for any of a variety of plants, such as those of the genera Hordeum, Oryza, Zea, and Triticeae . Other non-limiting examples of suitable plants include mosses, lichens and algae. In some cases, plants are of economic, social and/or environmental importance as food crops, fibrous crops, oilseeds, plants used in the forestry or pulp and paper industry, biofuel feedstock and/or ornamental plants. Non-limiting examples of crops include corn, rice, wheat, barley, sorghum, millet, oats, triticale rye, buckwheat, sweet corn, sugarcane, onions, tomatoes, strawberries, and asparagus.

[0145] Plants that can be obtained or improved using the methods and compositions described herein also include pineapple, banana, coconut, lilies, and herbs; and dicotyledonous plants such as, for example, peas, alfalfa, physalis, melon, chickpeas, chicory, clover, cabbage, lentils, soybeans, tobacco, potatoes, sweet potatoes, radishes, kale, rapeseed, apple trees, grapes, cotton, sunflower, arabidopsis, canola, citrus fruits (including orange, tangerine, kumquat, lemon, lime, grapefruit, tangerine, tangelo, citron, and pomelo), pepper, beans, and lettuce.

[0146] In some cases, the improved plant is difficult to experimental conditions. For example, it may take too long for a crop to grow sufficiently to evaluate an improved trait almost consistently across multiple iterations. Thus, the first plant from which the bacteria are initially isolated and/or the plurality of plants to which the genetically modified bacteria are used may be model plants, such as a plant more amenable to analysis under the required conditions. Non-limiting examples of model plants include Setaria , Brachypodium and Arabidopsis . The ability of bacteria isolated by the method of the present invention using a model plant can then be applied to another type of plant (eg crop) to confirm the acquisition of an improved trait.

[0147] Traits that can be improved by the methods described herein include any observable characteristics of a plant, including, for example, growth rate, growth, weight, color, taste, smell, changes in the plant's production of one or more compounds (including, for example, metabolites , proteins, drugs, carbohydrates, oils and any other compounds). Also contemplated is selection of plants based on genotypic information (eg, including a plant's gene expression profile in response to bacteria or identification of the presence of genetic markers, such as genetic markers associated with increased nitrogen fixation). Plants as opposed to the presence of a particular property or trait (such as a desired property or trait) can also be selected based on the absence, suppression, or inhibition of a particular property or trait (such as an undesirable property or trait).

EXAMPLES

[0148] The examples provided herein describe methods for isolating bacteria, analyzing bacteria and plants, and improving plant traits. The examples are provided for illustrative purposes only and should not be construed as limiting in any way.

Example 1 Isolation of Microorganisms from Plant Tissue

[0149] Topsoil was obtained in various agricultural areas of central California. Received twenty soils with different structural characteristics, including dense clay, peat loam, silty clay and loam. Seeds of various field corn, sweet corn, old non-hybrid corn and tomato were planted in each soil as shown in Table 1 .

crop type field corn sweet corn Old non-hybrid corn Tomato Varieties Mo17 Ferry-Morse "Golden Cross Bantam T-51" Victory Seeds "Moseby Prolific" Ferry-Morse Roma VF B73 Ferry-Morse "Silver Queen Hybrid" Victory Seeds "Reid's Yellow Dent" Stover Roma DKC 66-40 Ferry-Morse "Sugar Dots" Victory Seeds "Hickory King" Totally Tomatoes "Micro Tom Hybrid" DKC 67-07 Heinz 1015 DKC 70-01 Heinz 2401 Heinz 3402 Heinz 5508 Heinz 5608 Heinz 8504

Table 1: Types and varieties of crops planted in soils with different characteristics

[0150] Plants were uprooted after 2-4 weeks of growth and excess soil on root surfaces was removed with deionized water. After removing the soil from the plants, the surface was sterilized with whitewash and intensively washed in sterile water. A 1 cm section of the cleaned root was excised from the plant and placed in phosphate-buffered saline containing 3 mm steel pellets. A slurry was obtained by vigorous agitation of the solution on a Qiagen TissueLyser II.

[0151] The root and saline slurry was diluted and inoculated onto various types of growth media to isolate rhizospheric, endophytic, epiphytic, and other plant-associated microorganisms. R2A and Nfb agarose media were used to obtain single colonies, and Nfb semi-solid slant media were used to obtain populations of nitrogen-fixing bacteria. After 2-4 weeks of incubation in semi-solid Nfb slants, microbial populations were collected and streaked onto R2A agar to obtain single colonies as shown in Figure 1A-B . Single colonies were resuspended in a mixture of R2A and glycerol, subjected to PCR analysis and frozen at -80°C for further analysis. Approximately 1000 single colonies were obtained and referred to as "isolated microorganisms".

[0152] The isolates were then colony screened by PCR to detect the presence of nifH genes to identify diazotrophs. To analyze the presence of the nif cluster in each isolate, the previously described Ueda 19F/388R primer set was used, which has been shown to detect more than 90% of diazotrophs in screenings (Ueda et al. 1995; J. Bacteriol. 177: 1414-1417). Single colonies of isolated isolates were punctured, resuspended in PBS and used as a template for colony PCR as shown in Figure 2 . Colonies of isolates for which positive PCR bands were obtained were streaked again, and colony PCR and streaked were repeated twice to prevent false positive identification of diazotrophs. The isolated isolates were then designated as "candidate microorganisms".

Example 2 Characterization of Isolated Microorganisms

Sequencing, analysis and phylogenetic characterization

[0153] 16S rDNA sequencing with primer set 515f-806r was used to obtain preliminary phylogenetic identification of isolated and candidate microorganisms (see, for example, Vernon et al.; BMC Microbiol. 2002 Dec 23;2:39.). Microorganisms contained various genera including: Enterobacter , Burkholderia , Klebsiella , Bradyrhizobium , Rahnella , Xanthomonas , Raoultella , Pantoea , Pseudomonas , Brevundimonas , Agrobacterium and Paenibacillus , as shown in Table 2 .

Genus Isolates Genus Isolates Achromobacter 7 Paenibacillus one Agrobacterium 117 Paenisporosarcina 3 Agromyces one pantoea fourteen Alicyclobacillus one Pedobacter 16 Asticcacaulis 6 Pimelobacter 2 bacillus 131 Pseudomonas 212 Bradyrhizobium 2 Rhizobium four Brevibacillus 2 Rhodoferax one Burkholderia 2 Sphingobacterium 13 Caulobacter 17 Sphingobium 23 Chryseobacterium 42 Spingomonas 3 Comamonas one Sphingopyxis one Dyadobacter 2 Stenotrophomonas 59 Flavobacterium 46 Streptococcus 3 Halomonas 3 Variovorax 37 Leptothrix 3 Xylanimicrobium one Lysobacter 2 unidentified 75 Neisseria 13

Table 2: Diversity of microorganisms isolated from tomato plants as determined by 16S rDNA deep sequencing.

[0154] Next, the genomes of 39 candidate microorganisms were sequenced using the Illumina Miseq platform. Genomic DNA from pure cultures was isolated using a QIAmp DNA mini kit (QIAGEN) and total DNA libraries for sequencing were obtained from an independent supplier (SeqMatic, Hayward). The genome was then assembled using the A5 pipeline (Tritt et al. 2012; PLoS One 7(9):e42304). Genes were identified and annotated, and genes associated with the regulation and expression of nitrogen fixation were marked as targets of mutagenesis.

Transcriptome profiling of candidate microorganisms

[0155] To identify promoters that are active in the presence of environmental nitrogen, transcriptomic profiling of strain CI010 was performed. The CI010 strain was cultured in a defined nitrogen-free medium supplemented with 10 mM glutamine. Total RNA was isolated from these cultures (QIAGEN RNeasy kit) and subjected to RNAseq sequencing by HiSeq Illumina (SeqMatic, Fremont CA). Sequencing reads were mapped to CI010 genome data using Geneious and identified highly expressed genes under the control of proximal transcription promoters. Tables 3A-C list the genes and their relative expression levels as determined by total RNA RNAseq sequencing. Proximal promoter sequences were registered for use in mutagenesis of nif metabolic pathways, nitrogen utilization metabolic pathways, or other genes at the desired level of expression.

Assessing the convenience of gene manipulation

[0156] Microorganisms-candidates were characterized on the basis of the ability to transform and ease of manipulation of genes. First, the optimal utilization of the carbon source was determined by growing on a small panel of the appropriate medium, as well as the growth curve in nitrogen-free and rich media. Secondly, the natural antibiotic resistance of each strain was determined by the method of replicating and growing in liquid culture containing a panel of antibiotics used as selective markers of mutagenesis. Third, each strain was tested for its ability to transform by electroporation of a collection of plasmids. The plasmid collection contains a combinatorial extension of seven origins of replication, i.e., p15a, pSC101, CloDF, colA, RK2, pBBR1, and pRO1600, and four antibiotic resistance markers, i.e., CmR, KmR, SpecR, and TetR. This systemic compatibility assessment of origins of replication and resistance markers was used to identify vectors for plasmid-based mutagenesis of candidate microorganisms.

Example 3 Mutagenesis of Candidate Microorganisms

Mediated Red lambda knockout

[0157] Several candidate mutants were generated using plasmid pKD46 or a derivative thereof containing a kanamycin resistance marker (Datsenko et al. 2000; PNAS 97(12): 6640-6645). Knockout cassettes were constructed with 250 bp homology flanking the target gene and generated by PCR with overlap completion. Candidate microorganisms were transformed with pKD46, cultured in the presence of arabinose to induce the Lambda Red expression mechanism, prepared for electroporation, and transformed with knockout cassettes to obtain candidate mutant strains. Four candidate microorganisms and one laboratory strain, Klebsiella oxytoca M5A1, were used to generate thirteen candidates mutated in the nitrogen fixation regulatory genes nifL , glnB , and amtB , as shown in Table 4 .

Strain nifL glnB amtB M5A1 X X X CI006 X X X CI010 X X X CI019 X X CI028 X X

Table 4: List of single knockout mutants generated using Red-mediated lambda mutagenesis

Oligonucleotide-specific mutagenesis with Cas9 selection

[0158] Oligonucleotide-specific mutagenesis was used to localize genome changes in the E. coli DH10B rpoB gene, and mutants were selected using the CRISPR-Cas system. A mutagenic oligonucleotide (ss1283: "G*T*T*G*ATCAGACCGATGTTCGGACCTTCcaagGTTTCGATCGGACATACGCGACCGTAGTGGGTCGGGTGTACGTCTCGAACTTCAAAGCC", where * denotes a thiophosphate bond) was constructed to confer resistance to rifampicin via a 4 bp mutation. in the rpoB gene. Cells containing a plasmid encoding Cas9 were induced to express Cas9, prepared for electroporation, and then electroporated with a mutagenic oligonucleotide and a plasmid encoding constitutive expression of a guide RNA (nRNA) that directs Cas9 cleavage of the WT rpoB sequence. The electroporated cells were reconstituted in non-selective media overnight to ensure sufficient segregation of the resulting mutant chromosomes. After seeding on selection medium to select the coding nRNA plasmid, two of the ten colonies screened were shown to contain the desired mutation, while the rest were shown to be escape mutants resulting from a protospacer mutation in the nRNA plasmid or loss of the Cas9 plasmid. .

Red-mediated lambda mutagenesis with selection through Cas9

[0159] Received mutants of microorganisms-candidates CI006 and CI010 using Red-mediated lambda mutagenesis with selection by CRISPR-Cas. The knockout cassettes contained an endogenous promoter identified by transcriptome profiling (as described in Example 2 and shown in Table 3 ) and regions of ≈250 bp homology flanking the deletion target. CI006 and CI010 were transformed with plasmids encoding the Red lambda recombination system (exo, beta, gam genes) under the control of an arabinose inducible promoter and Cas9 under the control of an IPTG inducible promoter. In the obtained transformants, the Red and Cas9 recombination systems were induced and strains for electroporation were obtained. Then knockout cassettes and a plasmid with encoded selection nRNA were transformed into competent cells. After seeding on selective media with antibiotics for Cas9 plasmid and nRNA plasmid, 7 out of 10 screened colonies showed the desired knockout mutation, as shown in Figure 3 .

Example 4: Phenotyping of Candidate Molecules in vitro

[0160] In various mutants, the effect of exogenous nitrogen on the biosynthesis and activity of nitrogenase was determined. The acetylene reduction assay (ARA) was used to determine nitrogenase activity under pure culture conditions (Temme et. al. 2012; 109(18): 7085-7090). The strains were grown in sealed test tubes and the reduction of acetylene to ethylene was quantified using an Agilent 6890 gas chromatograph. The activity of candidate microorganisms and other candidate mutants grown in nitrogen fixation media supplemented with 0 to 10 mM glutamine in ARA shown in figures 4A-B and figures 10A-C .

[0161] Under anaerobic culture conditions, a range of glutamine and ammonia concentrations was determined, and the effect on nitrogen fixation activity was quantified. In wild-type cells, as the concentration of glutamine increased, the activity rapidly decreased. However, a class of mutations has been confirmed in a series of parental knockout mutations that mediate the expression of nitrogen fixation genes under conditions of glutamine concentration, which would otherwise suppress this activity in the wild type. As seen in Figure 4C , this profile was obtained from four different diazotrophic species. In addition, by reconfiguring the regulatory network using the identified genetic components, the level of nitrogen fixation activity was regulated in a predictable manner. This can be observed in Figure 4B , which illustrates strains CM023, CM021, CM015 and CI006. Strain CM023 is a weakly evolved strain; strain CM021 is a highly evolved strain; strain CM015 is a medium evolved strain; strain CI006 is a wild-type strain (strain 2). Ammonia released into culture supernatants was tested using an enzymatic assay (MEGAZYME). In the assay, the amount of NADPH consumed was determined at an optical density of 340 nm. The analysis was carried out in bacterial cultures grown in nitrogen-free, anaerobic environment with an initial density of 10 ⁹ cfu/ml. As seen in Figure 4D , in a panel of six evolved strains, one of the strains released up to 100 μM ammonia over a 48 hour period. In addition, as seen in Figure 11 , the double mutant exhibited greater ammonia release than the single mutant from which it was derived. This demonstrates the ability of microorganisms to produce ammonia in quantities in excess of their physiological requirements.

Transcriptome profiling of pure cultures

[0162] The transcriptional activity of CI006 was determined using the Nanostring Elements platform. Cells were grown in a nitrogen-free medium and 10 ⁸ cells were harvested after 4 hours of incubation. Total RNA was isolated using the Qiagen RNeasy kit. The purified RNA was sent to Core Diagnostics in Palo Alto, CA for probe hybridization and Digital Analyzer analysis as shown in Figure 5 .

Example 5: Phenotyping of Candidate Microorganisms in planta

Colonization of plants by microorganism candidates

[0163] Colonization of desired host plants by candidate microorganisms was quantified through short term plant growth experiments. Maize plants were inoculated with strains expressing RFP from a plasmid or with a Tn5-integrated RFP expression cassette. Plants were grown in sterilized sand and non-sterile peat medium, and inoculation was carried out by applying 1 ml of cell culture with a pipette directly to the emerging plant coleoptile three days after germination. Plasmids were maintained by watering the plants with a solution containing the appropriate antibiotic. Three weeks later, plant roots were collected, washed three times in sterile water to remove visible soil, and divided into two samples. One root sample was analyzed by fluorescence microscopy to determine localization profiles of candidate microorganisms. Microscopy was performed on 10 mm parts of the best intact plant roots, as shown in figure 6 .

[0164] A second quantitative method for assessing colonization has been developed. A quantitative PCR analysis was carried out on preparations of total DNA from plant roots inoculated with endophytes. Corn seeds (Dekalb DKC-66-40) were germinated in pre-autoclaved sand in a 6.35 cm by 6.35 cm by 25.4 cm pot. location of seeds. 1 ml of this overnight culture is approximately equivalent to approximately 10 ⁹ cfu, with a variation within 3 times each other depending on the strain used. Each seedling was fertilized 3 times a week with 50 ml of modified Hoagland's solution supplemented with 2.5 mM or 0.25 mM ammonium nitrate. Four weeks after planting, root samples were collected for DNA extraction. Soil residues were washed off using a pressurized water spray. These tissue samples were then homogenized using the QIAGEN Tissuelyzer and then DNA was isolated using the QIAmp Mini DNA Isolation Kit (QIAGEN) following the recommended protocol. These isolated DNA samples were subjected to qPCR analysis using a Stratagene Mx3005P RT-PCR device using primers that are designed (using Primer BLAST NCBI) to be specific to the loci within each endophyte genome. The presence of copies of endophyte genomes was quantified. To further confirm the identification of endophytes, the sequencing of the PCR amplification products was performed and the presence of the correct sequence was confirmed. A summary of the colonization profiles of candidate strains CI006 and CI008 is presented in Table 5 . Strain CI008 demonstrated a colonization rate of up to 10 ⁷ x CFU/g ww of the root.

Strain Colonization Rate (cfu/g ww) CI006 1.45×10 ⁵ CI008 1.24×10 ⁷

Table 5: Maize colonization determined by qPCR

RNA profiling in planta

[0165] Biosynthesis of nif pathway components in planta was assessed by determining the transcription of nif genes. Total RNA was obtained from root tissues of plants inoculated with CI006 (planting methods described previously). RNA isolation was performed using the RNEasy mini kit according to the recommended protocol (QIAGEN). The total RNA of these plant tissues was then analyzed using Nanostring Elements kits (NanoString Technologies, Inc.) using probes specific for the nif genes in the CI006 strain genome. Data on nif gene expression in planta are summarized in Table 6 . Expression of nifH genes was detected in plants inoculated with strain CM013, while nifH expression was not detected in plants inoculated with CI006. Strain CM013 is a derivative of strain CI006 in which the nifL gene has been knocked out.

[0166] Highly expressed CM011 genes, ranked transcripts in the so-called. per million (TPM), measured in planta under fertilization conditions. Promoters controlling the expression of some of these highly expressed genes have been used as templates for homologous recombination at the target nitrogen fixation and assimilation loci. RNA samples from greenhouse-grown CM011 inoculated plants were isolated, rRNA removed using the Ribo-Zero kit, sequenced using the Truseq Illumina platform, and mapped back to the CM011 genome. Highly expressed CM011 genes are shown in Table 7 .

Strains Relative transcripts CI006 9.4 CM013 103.25

Table 6: Expression of nifH in planta

Gene name Gene position Direction Total number of reads TPM (transcripts in tons per million) CDS rpsH 18196-18588 reverse 4841.5 27206.4 CDS rplQ 11650-12039 reverse 4333 24536.2 CDS rpsJ 25013-25324 reverse 3423 24229 CDS rplV 21946-22278 reverse 3367.5 22333 CDS rpsN 18622-18927 reverse 2792 20150.1 CDS rplN 19820-20191 reverse 3317 19691.8 CDS rplF 17649-18182 reverse 4504.5 18628.9 CDS rpsD 13095-13715 reverse 5091.5 18106.6 CDS rpmF 8326-8493 direct 1363.5 17923.8 CDS rplW 23429-23731 reverse 2252 16413.8 CDS rpsM 14153-14509 reverse 2269 14036.2 CDS rplR 17286-17639 reverse 2243.5 13996.1 CDS rplC 24350-24979 reverse 3985 13969.2 CDS rplK 25526-25954 reverse 2648.5 13634.1 CDS rplP 20807-21217 reverse 2423 13019.5 CDS rplX 19495-19809 reverse 1824 12787.8 CDS rpsQ 20362-20616 reverse 1460.5 12648.7 CDS bhsA 3 79720-79977 reverse 1464 12531.5 CDS rpmC 20616-20807 reverse 998.5 11485 CDS rpoA 12080-13069 reverse 4855 10830.2 CDS rplD 23728-24333 reverse 2916.5 10628.5 CDS bhsA 1 78883-79140 reverse 1068 9141.9 CDS rpsS 22293-22571 reverse 1138.5 9011.8 CDS rpmA 2210-2467 direct 1028.5 8803.7 CDS rpmD 16585-16764 reverse 694.5 8520.8 CDS rplB 22586-23410 reverse 3132 8384 CDS rpsC 21230-21928 reverse 2574.5 8133.9 CDS rplE 18941-19480 reverse 1972.5 8066.9 CDS rplO 16147-16581 reverse 1551 7874.2 CDS of SecY translocase subunit precursor protein 14808-16139 reverse 4657 7721.2 CDS rpsE 16771-17271 reverse 1671.5 7368 CDS rpsK 13746-14135 reverse 1223.5 6928.2 CDS tufA 27318-28229 reverse 2850 6901.3 CDS rpmI 38574-38771 direct 615 6859.5 CDS rplU 1880-2191 direct 935.5 6621.7 CDS rplT 38814-39170 direct 1045 6464.4 CDS bhsA 2 79293-79550 reverse 754 6454.1 CDS rpmB 8391-8627 reverse 682 6355.1 CDS rplJ 23983-24480 reverse 1408 6243.9 CDS fusA 2 481-2595 reverse 5832 6089.6 CDS rpsA 25062-26771 reverse 4613 5957.6 CDS rpmJ 14658-14774 reverse 314 5926.9 CDS rpsR 52990-53217 direct 603 5840.7 CDS rpsG 2692-3162 reverse 1243 5828.2 CDS rpsI 11354-11746 reverse 980.5 5509.8 CDS cspC 1 8091-8300 reverse 509 5352.8 CDS rpsF 52270-52662 direct 916 5147.4 CDS rpsT 55208-55471 reverse 602 5035.9 CDS infC 38128-38478 direct 755 4750.3 CDS cspG 30148-30360 direct 446 4624.2

Table 7

Analysis ^fifteen N

[0167] The main method for demonstrating fixation uses the ¹⁵ N isotope of nitrogen, which is in the atmosphere at a set level relative to ¹⁴ N. By adding increased levels ^{of 15} N to each fertilizer or atmosphere, fixation can be observed or directly in increased amounts of ¹⁵ N fixed from the atmosphere supplemented with ¹⁵ N ₂ gas (Yoshida 1980), or indirectly through dilution of enriched fertilizer with atmospheric N ₂ gas in plant tissues (Iniguez 2004). The dilution method allows the accumulation of fixed nitrogen to be observed during plant growth, while the ¹⁵ N ₂ gas method is limited to determining the fixation that occurs over a short interval during which the plant can be grown in a confined atmosphere (rate measurements). Thus, the gas method is better suited for determining specificity (since any elevated levels ^{of 15} N ₂ in the plant above atmospheric levels can be unambiguously correlated with fixation), but they cannot show cumulative activity.

[0168] To determine the fixation activity of improved strains relative to wild-type and non-inoculated maize plants, both assays were performed and increased fixation levels were observed in several of the improved strains in planta ( Figure 12 , Figure 14A and Figure 14B ). These assays are important in demonstrating that in vitro activity of test strains is consistent with in vivo results. In addition, these assays make it possible to determine the effect of a fertilizer on the activity of a strain, suggesting appropriate functionality under agricultural conditions. Similar results were observed when wild-type and improved strains were inoculated with Setaria plants ( Figure 13 ). In planta fixation activity shown in Figures 14A-14C was further confirmed by transcriptomic data. Evolved strains show an increased level of nifH transcripts relative to wild-type variants. In addition, the level of nitrogen provided by microorganisms in planta also correlated with the level of plant colonization per plant. These results ( Figure 12, Figure 13, Figures 14A-14C, Figure 15A and Figure 15B ) support the hypothesis that a microorganism is the likely cause of the increase in atmospheric nitrogen observed in plant tissues due to improved regulation of the nif gene cluster. In addition to the direct determination of fixation, the effect of plant inoculation with improved strains was determined in a plant biomass analysis under nitrogen deficient conditions. Although plant biomass can be associated with a variety of possible microorganism-plant interactions, it would be expected that the addition of fixed nitrogen could influence plant phenotype under nitrogen deficient conditions. Inoculated plants were grown under complete nitrogen-free conditions and a significant increase in leaf area, wet and dry weight of shoots, and wet and dry weight of roots was observed in inoculated plants relative to untreated control plants ( Figure 14C ). Although these differences cannot be attributed solely to nitrogen fixation, they support the conclusion that improved strains actively provide nitrogen to plants. Corn and Setaria plants were grown and inoculated as described above. Fertilizer containing 1.2% ¹⁵ N was regularly added to plants by watering. Nitrogen fixation by microorganisms was quantified by determining the level of ¹⁵ N in plant tissue. Fourth leaf tissue was obtained at 4 weeks after planting and dried. Dried leaf samples were homogenized using pellets (QIAGEN Tissuelyzer) and aliquoted into IRMS tin capsules (MBL Stable Isotope Laboratory at The Ecosystems Center, Woods Hole, MA). Atmospheric nitrogen (NDFA) was calculated and nitrogen production of CI050 and CM002 is shown in Figure 7 .

Analysis of phytohormone production

[0169] Previously, the dwarf tomato ( Solanum lycopersicum ) variety "Micro-Tom" (Cohen 1996; J Am Soc Hortic Sci 121:520-524) was used to investigate the effect of indole-3-acetic acid on fruit ripening by in vitro assay . To assess the production and secretion of phytohormones by candidate microorganisms, a plate screening assay using immature Micro-Tom fruits was developed. Twelve-well tissue culture test plates were prepared by filling the wells with agarose medium, allowing it to solidify, and topping the agar surface with 10 µl of an overnight microorganism culture as shown in Figure 8 . Agar wells contained increased amounts of gibberellic acid (GA), but no bacterial cultures were used as positive controls and standards. Flowers cut from growing Micro-Tom plants a day after the start of flowering were placed in the agar in the area of application of the bacterial culture stem first. These flowers were observed for 2-3 weeks, after which the fruits were collected and weighed. An increase in the weight of the plant fruit in several repetitions indicated the production of plant hormones by the inoculated microorganisms, as shown in figure 9 .

Example 6: Host-Microorganism Cyclic Evolution

[0170] Corn plants were inoculated with CM013 and grown for 4 weeks to approximately the V5 growth stage. Plants showing improved nitrogen uptake from microbial sources as measured by ¹⁵ N analysis were uprooted and roots washed using pressurized water to remove the underlying soil. A 0.25 g root was cut and washed in PBS to remove small soil particles and unattached microorganisms. Tissue samples were homogenized using 3 mm steel beads in a QIAGEN TissueLyser II. The homogenate was diluted and plated on SOB agarose media. Single colonies were resuspended in liquid media and subjected to PCR analysis of 16s rDNA and mutations unique to the inoculated strain. The process of isolation of the microorganism, mutagenesis, inoculation and re-isolation can be repeated several times with the improvement of the characteristics of the microorganism, the characteristics of plants and the ability of microorganisms to colonize.

Example 7: Compatibility in different geographical conditions

[0171] The ability of the improved microorganisms to colonize the inoculated plant is critical to the success of the plant in the field. Although the isolation methods described are designed to select from soil microorganisms that may be closely related to crops such as corn, many strains cannot effectively colonize across a range of plant genotypes, environmental types, soil types, or inoculation conditions. Since colonization is a complex process that requires a number of interactions between a strain of microorganisms and a host plant, screening for colonization ability has become the main way to select priority strains for further development. Early attempts at assessing colonization used fluorescently labeled strains, which were effective but time consuming and did not scale across strains. Since colonization activity cannot be directly improved, it is critical to select potential production candidates from strains that are natural colonizers.

[0172] An assay was developed to test for stable colonization by wild-type strains of any given host plant using qPCR and primers designed to be specific for the strain in a community sample. This assay is designed to rapidly determine the rate of colonization of microorganisms from maize tissue samples. Initial tests using strains assessed as likely colonizers using fluorescence microscopy and plate methods demonstrated that the qPCR approach can be quantitative and scalable.

[0173] A typical analysis is carried out as follows: plants, mainly varieties of corn and wheat, are grown in peat potting mix in a greenhouse in six repetitions per strain. Four or five days after planting, 1 ml of the impregnation of cultures of bacteria in the early stationary phase, diluted to an OD ₅₉₀ of 0.6-1.0 (approximately 5×10 ⁸ CFU/ml), is pipetted onto an ascending coleoptile. The plants are irrigated with tap water only and left to rati for four weeks, followed by sampling, during which the plants are uprooted and the roots thoroughly washed to remove most of the peat residue. Samples of clean roots are cut out and homogenized to obtain a suspension of plant debris cells and associated bacterial cells. The authors have developed a high-throughput DNA isolation protocol that allows one to efficiently obtain a mixture of plant and bacterial DNA for use as a template for qPCR. Based on an experiment in a sharp increase in the number of bacterial cells, this method of DNA extraction obtains a quantitative sample of bacterial DNA relative to the wet weight of the roots. Each strain is evaluated using strain-specific primers designed using Primer BLAST (Ye 2012) and compared to background amplification in non-inoculated plants. Since some primers in non-inoculated plants showed side amplification, colonization is determined by the presence of amplification or increased amplification of the corresponding product compared to the background level.

[0174] This analysis was used to determine the compatibility of the product of microorganisms in different soil geographic conditions. Field soil qualities and field conditions can have a very large influence on the action of the microbial product. Soil pH, water retention capacity, and competing microorganisms are just a few examples of soil factors that can affect inoculum viability and colonization ability. Colonization analysis was performed using three different soil types sampled as plant growth media from agricultural fields in California ( Figure 16A ). An intermediate inoculation density was used to approximate real agricultural conditions. Within 3 weeks, strain 5 colonized all plants at a level of 10 ⁶ to 10 ⁷ CFU/g wet weight. After 7 weeks of plant growth, the evolved version of strain 1 showed high levels of colonization (10 ⁶ cfu/g wet weight) in all soil types. ( Figure 16B) .

[0175] In addition, to evaluate colonization under challenging field conditions in a 1-acre field in San Luis Obispo, a trial was initiated in June 2015 to evaluate the impact and colonization of seven wild-type strains on two varieties of field corn. Agrotechnical design and testing was contracted out to a field research organization, Pacific Ag Research. For inoculation, the same peat seed coating method was used that was tested in the inoculation method experiments. During the growing season, plant samples were collected to assess the colonization of the root and the interior of the stem. Samples were collected from three replicate plots after each treatment at four and eight weeks post planting, and from all six replicate sites after each treatment shortly before collection at 16 weeks. Additional samples were collected from all six replicate sites after strain 1 and strain 2 inoculation treatments, as well as untreated controls, 12 weeks later. The number of cells per gram wet weight of washed roots was evaluated as in other colonization assays using qPCR and strain-specific primers. Two strains, strain 1 and strain 2, showed stable and ubiquitous root colonization that peaked at 12 weeks and then declined sharply ( Figure 16C ). Although strain 2 appears to be present at an order of magnitude lower than strain 1, it has been found to be more constant in plant to plant amounts. Apparently, none of the strains effectively colonizes the interior of the stem. In support of the qPCR colonization data, both strains were successfully reisolated from root samples using plates and 16S sequencing to identify isolates of the respective sequence.

[0176] The use of terms in the singular within the scope of the description of the invention (especially within the scope of the following claims) should be considered as referring to the singular and plural, unless otherwise indicated herein or clearly dictated by the context. Unless otherwise indicated, the terms "comprising", "having", "including" and "containing" should be considered as open terms (ie, meaning "including as non-limiting examples"). Unless otherwise indicated herein, the indication of ranges of values in this document serves solely as a way of shortening the individual indication of each individual value that is in the specified range, and each individual value is included in the description as if it were individually specified in this document. For example, if the range is 10-15, then 11, 12, 13, and 14 are also included. Unless otherwise indicated herein or otherwise explicitly dictated by the context, all methods described herein can be performed in any suitable order. Unless otherwise indicated, the use of any and all examples or illustrative language (eg, "such as") given herein is intended solely to better describe the invention and is not intended to limit the scope of the invention. None of the language in the description should be taken as an indication that any non-claimed element is essential to the practice of the invention.

[0177] While preferred embodiments of the present invention are provided and described herein, those skilled in the art will recognize that such embodiments are provided by way of example only. Many variations, changes and changes can be made by those skilled in the art without deviating from the invention. It should be understood that various alternatives to the embodiments of the invention described herein can be used in the practice of the invention. It is to be understood that the scope of the invention is defined by the following claims and that the methods and structures within the scope of those claims and their equivalents are thus encompassed.

[0178] Table 3A

Name Minimum Maximum Length Direction murein lipoprotein CDS 2929898 2930134 237 direct membrane protein CDS 5217517 5217843 327 direct CDS of zinc/cadmium binding protein 3479979 3480626 648 direct CDS of acyl carrier protein 4563344 4563580 237 reverse CDS ompX 4251002 4251514 513 direct CDS of DNA-binding protein HU-beta 375.156 375.428 273 direct CDS sspA 629.998 630.636 639 reverse CDS tatE 3199435 3199638 204 reverse CDS of the LexA repressor 1850457 1851065 609 direct CDS hisS <3999979 4001223 >1245 direct

[0179] Table 3B

Name absolute reliability of differential expression Differential expression ratio RNAseq_nifL - Total number of reads RNAseq_nifL - Total number of transcripts RNAseq_WT - Total number of reads RNAseq_WT - Total number of transcripts murein lipoprotein CDS 1000 -1.8 12950.5 10078.9 5151.5 4106.8 membrane protein CDS 1000 -1.3 9522.5 5371.3 5400 3120 CDS of zinc/cadmium binding protein 3.3 1.1 6461 1839.1 5318 1550.6 CDS of acyl carrier protein 25.6 1.6 1230.5 957.6 1473.5 1174.7 CDS ompX 1.7 1.1 2042 734.2 1687.5 621.5 CDS of DNA-binding protein HU-beta 6.9 -1.3 1305 881.7 725 501.8 CDS sspA 0.2 one 654 188.8 504.5 149.2 CDS tatE 1.4 1.3 131 118.4 125 115.8 CDS of the LexA repressor 0.1 -1.1 248 75.1 164 50.9 CDS hisS 0 -1.1 467 69.2 325 49.3

[0180] Table 3C

membrane protein CDS GGTTCACATAAACATAATTATCGCCACGGCGATAGCCGTACGCTTTTTGCGTCACAACATCCATGGTGAAGCCGGCTTTTTCAAGAACACGCGCCACCTCATCGGTCTTAAATACATACTCATTCCTCATTATCTTTTACCGCACGTTAACCTTACCTTATTCATTAAAGGCAACGCTTTCGGAATATTCCATAAAGGGCTATTTACAGCATAATTCAAAAATCTTGTCCTACACTTATAGACTCAATGGAATTAG ATGGCCAACCGAGCAAACCGCAACAACGTAGAAGAGAGCGCTGAAGATATCCATAACGATGTCAGCCAATTAGCGGATACGCTGGAAGAGGTGCTGAAATCGTGGGGCAGCGACGCCAAAGACGAAGCGGAGGCCGCGCGCAAAAAAGCGCAGGCGCTGCTGAAAGAGACCCGCGCCCGGCTTAACGGCAACAACCGCGTCCAGCAGGCGGCGTGCGACGCCATGGGCTGCGCTGACAGCTACGTGCGCGACAAACCGTGGCAAAGCGTCGGCGCCGCAGCAGCCGTTGGGGTATTTATTGGCGTATTACTGAATTTACGTCGATAA ATGTATTTAAGACCCGATGAGGTGGCGCGTGTTCTTGAAAAAGCCGGCTTCACCATGGATGTTGTGACGCAAAAAGCGTACGGCTATCGCCGTGGCGATAATTATGTTTATGTGAACCGTGAAGCTCGTATGGGGCGTACCGCGTTAATTATTCATCCGGCTTTAAAAGAGCGCAGCACAACGCTTGCGGAGCCCGCGTCGGATATCAAAACCTGCGATCATTATGAGCAGTTCCCGCTCTATTTAGCGGGGGATGCTCAACAGCATTATGGTATTCCACACGGGTTCAGTTCGCGAATGGCGCTTGAGCGTTTTCTGAGTGGCCTGTTTGGCGAAACGCAGTATAGCTGA

CDS of zinc/cadmium binding protein GCGCGGAAAATCGACGCATAGCGCATTCTCAGAAGCCGGCCTGGTCTCGGTGGAAAAGCGAATCTTTCCCACGACCGCCGGGCCTTTAACAAAAGAATCAATGACCTGATTAATGTCGCTATCCATTCTCTCTCCGCGTAATGCGATCTTTTCATCATCATACCTAACAAACTGGCAGAGGGAAAAGCCGCGCGGTTTTTCTGCGAAGTGTATTGTAAGATTTGTTTGATATTTTATATCGTA ATGACCAAAAAGATTTCCGCCCTAGCGTTTGGCATTGGCATGGTAATGGCGAGCAGCCAGGCTTTTGCCCACGGTCACCATAGTCATGGCCCGGCGCTGACCGAAGCGGAACAAAAGGCGAGTGAAGGCATTTTTGCTGACCAGGACGTAAAGGACAGGGCGCTGAGCGACTGGGAGGGGATCTGGCAGTCGGTTAACCCCTATCTGCTGAACGGGGATTTAGATCCGGTTCTGGAGCAGAAGGCCAAAAAGGCCGGTAAAAGCGTGGCGGAATATCGGGAATATTATAAGAAGGGCTACGCTACCGATGTCGACCAGATTGGTATCGAGGATAACGTCATGGAGTTTCACGTCGGGAAAACCGTCAACGCCTGTAAGTACAGCTATTCCGGTTACAAAATTCTGACCTACGCATCCGGTAAAAAAGGCGTGCGCTACCTGTTCGAATGCCAGCAGGCGGATTCAAAAGCGCCGAAGTTTGTTCAGTTTAGCGATCACACCATCGCGCCACGCAAGTCCCAGCATTTCCACATCTTTATGGGCAATGAGTCCCAGGAAGCGCTGCTGAAAGAGATGGATAACTGGCCAACCTACTATCCTTATGCGCTGCATAAAGAGCAGATTGTCGACGAAATGCTGCACCACTAA ATGGATAGCGACATTAATCAGGTCATTGATTCTTTTGTTAAAGGCCCGGCGGTCGTGGGAAAGATTCGCTTTTCCACCGAGACCAGGCCGGCTTCTGAGAATGCGCTATGCGTCGATTTTCCGCGCCTCGAAATCATGCTTGCGGGTCAGCTTCACGATCCGGCGATTAAAGCCGATCGCGCCCAGCTCATGCCGCACGATGTGCTGTATATTCCCGCTGGCGGATGGAATGACCCGCAATGGCTGGCGCCCTCCACTCTGCTCACTATCTTATTTGGTAAACAGCAGCTGGAATTCGTCCTGCGCCACTGGGACGGCAGCGCGCTTAACGTGCTGGATAAACAGCAGGTTCCGCGCCGCGGTCCCCGGGTCGGCTCTTTTCTGCTGCAGGCGCTGAATGAAATGCAGATGCAGCCGCGGGAGCAGCACACGGCCCGCTTTATTGTCACCAGCCTGCTCAGCCACTGTGCCGATCTGCTGGGCAGCCAGGTACAAACCTCATCGCGCAGCCAGGCGCTTTTTGAAGCGATTCGTAAGCATATTGACGCCCACTTTGCCGACCCGTTAACCCGGGAGTCGGTGGCGCAGGCGTTTTACCTCTCGCCAAACTATCTATCCCACCTGTTCCAGAAATGCGGGCCAATGGGCTTTAACGAGTATCTGAATCACATCCGCCTGGAGCAGGCCAGAATGCTGTTAAAAGGCCACGATATGAAAGTGAAAGATATCGCCCACGCCTGCGGTTTCGCCGACAGCAACTACTTCTGCCGCCTGTTTCGCAAAAACACCGAACGCTCGCCGTCGGAGTATCGCCGTCAATATCACAGCCAGCTGACGGAAAAAACAGCCCCGGCAAAAAACTAG

CDS of acyl carrier protein CTGACGAAGCGAGTTACATCACCGGTGAAACTCTGCACGTCAACGGCGGAATGTATATGGTCTGACCGAGATTTGCGCAAAACGCTCAGGAACCGCGCAGTCTGTGCGGTTCACTGTAATGTTTTGTACAAAATGATTTGCGTTATGAGGCAAACAGCCGCAAAATAGCGTAAAATCGTGGTAAGACCTGCCGGGATTAGAAATTTCGCGATTTTTCAACATTTTATACACTACT ATGAGCACTATCGAAGAACGCGTTAAGAAAATTATCGGCGAACAGCTGGGCGTTAAGCAGGAAGAAGTTACCAACAATGCTTCCTTCGTTGAAGACCTGGCGCTGATTCTCTTGACACCGTTGAGCTGGTAATGGCTCTGGAAGAAGAGTTTGATACTGAGATTCCGGACGAAGAAGCTGAGAAAATCACTACTGTTCAGGCTGCCATTGATTACATCAACGGCCACCAGGCGTAA ATGAGTTTTGAAGGAAAAATCGCGCTGGTTACCGGTGCAAGTCGCGGGATTGGCCGCGCAATCGCTGAAACGCTCGTTGCCCGTGGCGCGAAAGTTATCGGGACTGCGACCAGCGAAAGCGGCGCGCAGGCGATCAGCGATTATTTAGGTGCTAACGGTAAAGGTCTGCTGCTGAATGTGACCGATCCTGCATCTATTGAATCTGTTCTGGGAAATATTCGCGCAGAATTTGGTGAAGTTGATATCCTGGTGAACAATGCCGGGATCACTCGTGATAACCTGTTAATGCGCATGAAAGATGATGAGTGGAACGATATTATCGAAACCAACCTGTCATCTGTTTTCCGTCTGTCAAAAGCGGTAATGCGCGCTATGATGAAAAAGCGTCATGGACGTATTATCACTATCGGTTCTGTGGTTGGTACCATGGGAAATGCGGGTCAGGCCAACTACGCTGCGGCGAAAGCGGGTCTGATTGGCTTCAGTAAATCACTGGCTCGCGAAGTTGCGTCCCGCGGTATTACTGTAAACGTTGTTGCTCCGGGCTTTATTGAAACGGACATGACGCGTGCGCTGACCGATGAGCAGCGTGCGGGTACGCTGGCGGCAGTTCCTGCGGGGCGCCTCGGCTCTCCAAATGAAATCGCCAGTGCGGTGGCATTTTTAGCCTCTGACGAAGCGAGTTACATCACCGGTGAAACTCTGCACGTCAACGGCGGAATGTATATGGTCTGA

CDS ompX ACGCCTGGGGCGCCGACCAGCGGGAAGAGTGATTTGGCCAACGAGGCGCCGCTCTGAATGGAAATCATGGCGATTAAAAATAACCAGTATCGGCAACCATGCCGGTACCTTACGAGACGAGCCGGGCATCCTTTCTCCTGTCAATTTTGTCAAATGCGGTAAAGGTTCCAGTGTAATTGAATTACCCCATGCGCCGGTTGAGCTAATGGCTTGAAAAAAAAGGGTCTTAAAG ATGAATAAAATTGCACGTTTTTCAGCACTGGCCGTTGTTCTGGCTGCATCCGTAGGTACCACTGCTTTCGCTGCGACTTCTACCGTTACCGGTGGCTACGCGCAGAGCGACATGCAGGGTGAAGCGAACAAAGCTGGCGGTTTCAACCTGAAGTACCGCTACGAGCAAGACAACAACCCGCTGGGTGTTATCGGTTCTTTCACCTACACCGAAAAAGATCGTTCTGAATCTGGCGTTTACAAAAAAGGCCAGTACTACGGCATCACCGCAGGTCCGGCTTACCGTCTGAACGACTGGGCTAGCATCTACGGCGTAGTGGGTGTTGGTTACGGTAAATTCCAGGACAACAGCTACCCGAACAAATCTGATATGAGCGACTACGGTTTCTCTTACGGCGCTGGTCTGCAGTTCAACCCGATCGAAAACGTTGCCCTGGACTTCTCCTACGAGCAGTCTCGCATTCGTAACGTTGACGTTGGCACCTGGATTGCTGGCGTAGGTTACCGCTTCTAA ATGCCCGGCTCGTCTCGTAAGGTACCGGCATGGTTGCCGATACTGGTTATTTTAATCGCCATGATTTCCAT

CDS of DNA-binding protein HU-beta TCTGATTCCTGATGAAAATAAAACGCGACCTTGAAGAAATTCCGGATAACGTTATCGCCGATTTAGATATCCATCCGGTGAAACGAATCGAGGAAGTTCTGGCACTTGGCTACAGAACGAACCGTTTGGAATGGAAGTCGTCACGGCAAAATAGTGATTTCGCGCAAATAGCGCTAAGAAAAATAGGGCTGGTAAGTAAATTCGTACTTGCCAGCCTTTTTTTGGCTCTGTAGCTAACTGGATCG GTGAATAAATCTCAACTGATTGACAAAATTGCTGCCGGTGCGGACATTTCTAAAGCCGCAGCTGGACGTGCGTTAGATGCTTTAATCGCTTCTGTTACTGAATCTCTGCAGGCTGGAGATGACGTTGCGCTGGTAGGGTTTGGTACTTTTGCTGTTAAAGCGCGCTGCCCGTACTGGTCGCAATCCGCGAAAACAGGCAAAGAAATCGAACCATCGCGGCTGCTAAAGTTCCGTAAGGTTAACT ATGAATCCTGAGCGTTCTGAACGCATTGAAATCCCCGTATTGCCGTTGCGCGATGTGGTGGTTTATCCGCACATGGTCATACCCCTGTTTGTAGGGCGGGAAAAATCTATCCGTTGTCTCGAAGCAGCCATGGACCATGATAAAAAAATCATGCTGGTTGCGCAGAAAGAAGCCTCGACGGATGAGCCGGGTGTAAACGATCTTTTCACCGTCGGGACCGTGGCGTCTATTTTGCAAATGCTGAAGCTACCGGACGGTACTGTTAAAGTGCTGGTCGAAGGTTTGCAGCGCGCGCGCATCTCTGCGCTGTCTGATAATGGCGAACATTTTTCGGCGAAGGCGGAATACCTTGAATCGCCGGCGATTGACGAACGCGAGCAGGAAGTGCTGGTTCGTACCGCTATCAGCCAGTTTGAAGGCTACATCAAGCTGAACAAAAAAATCCCTCCGGAAGTGCTGACGTCGCTGAATAGCATCGACGATCCGGCGCGTCTGGCGGATACCATCGCTGCGCATATGCCGCTGAAGCTGGCGGACAAACAGTCCGTGCTGGAGATGTCCGACGTTAACGAGCGTCTGGAATATCTGATGGCGATGATGGAGTCGGAAATCGATCTGCTGCAGGTGGAGAAGCGTATTCGCAACCGCGTGAAAAAGCAGATGGAGAAATCTCAGCGCGAGTACTATCTGAATGAGCAAATGAAAGCCATTCAAAAAGAGCTCGGCGAGATGGACGACGCCCCGGACGAGAACGAAGCGCTGAAGCGTAAGATCGACGCGGCGAAAATGCCGAAAGAGGCAAAAGAGAAAACCGAAGCGGAACTGCAAAAACTGAAAATGATGTCCCCGATGTCGGCGGAAGCGACCGTCGTTCGCGGCTACATCGACTGGATGGTGCAGGTACCGTGGAACGCTCGCAGCAAGGTTAAAAAAGACCTGCGTCAGGCTCAGGAGATCCTCGATACCGATCACTACGGCCTTGAGCGCGTGAAGGATCGCA TTCTTGAGTACCTCGCGGTGCAGAGCCGTGTTAACAAGCTCAAAGGGCCGATCCTGTGCCTGGTTGGGCCTCCGGGGGTAGGTAAAACCTCTCTCGGCCAATCCATCGCCAAAGCAACTGGACGCAAATATGTGCGTATGGCGCTGGGCGGCGTGCGTGATGAAGCGGAAATCCGCGGTCACCGCCGTACCTATATTGGCTCAATGCCGGGCAAACTGATCCAGAAAATGGCTAAAGTGGGCGTTAAAAACCCGCTGTTCTTGCTGGATGAGATCGACAAGATGTCTTCTGACATGCGCGGCGATCCGGCCTCGGCGCTGCTGGAGGTGTTGGATCCGGAACAGAACGTGGCCTTTAACGACCACTATCTGGAAGTGGATTACGATCTCAGCGACGTGATGTTCGTTGCGACCTCTAACTCCATGAACATCCCGGCGCCGCTGCTGGATCGTATGGAAGTGATCCGCCTCTCCGGCTATACCGAAGATGAGAAGCTAAACATCGCCAAACGCCATCTGCTGTCAAAACAGATTGAGCGTAACGCGCTCAAGAAAGGCGAGCTGACGGTGGATGACAGCGCGATTATCGGCATCATTCGCTACTACACCCGTGAAGCAGGCGTGCGTGGTCTGGAGCGTGAAATCTCGAAACTGTGCCGCAAAGCGGTGAAACAGCTGCTGCTGGATAAGTCGCTGAAACACATCGAGATTAACGGCGACAACCTGCACGATTTCCTTGGCGTGCAGCGCTACGACTATGGTCGTGCGGATAGCGAAAACCGCGTAGGTCAGGTGACCGGACTGGCGTGGACGGAAGTGGGCGGCGATCTGCTGACCATTGAAACCGCCTGCGTTCCGGGTAAAGGCAAACTGACCTACACCGGTTCACTGGGTGAAGTCATGCAGGAATCCATCCAGGCGGCGCTGACGGTGGTTCGTTCACGTGCGGATAAGCTGGGTATTAACTCAGACTTTTACGAAAAACGTGATATTCACGTTCA CGTGCCGGAAGGCGCGACGCCGAAGGATGGTCCAAGCGCCGGTATCGCGATGTGCACCGCGCTGGTTTCCTGTCTGACGGGTAATCCGGTACGCGCCGACGTGGCGATGACCGGTGAGATTACCCTCCGTGGCCAGGTATTGCCGATTGGTGGTCTGAAGGAAAAACTGTTGGCCGCGCATCGCGGCGGCATTAAGACTGTTCTGATTCCTGATGAAAATAAACGCGACCTTGAAGAAATTCCGGATAACGTTATCGCCGATTTAGATATCCATCCGGTGAAACGAATCGAGGAAGTTCTGGCACTTGCGCTACAGAACGAACCGTTTGGAATGGAAGTCGTCACGGCAAAATAG

CDS sspA GTAAGAAAGTCGGCCTGCGTAAAGCACGTCGTCGTCCTCAGTTCTCCAAACGTTAATTGTTTTCTGCTCACGCAGAACAATTTGCGAAAAAACCCGCTTCGGCGGGTTTTTTTATGGATAAATTTGCCATTTTCCCTACAAACGCCCCATTGTTACCACTTTTTCAGCATTTCCAGAATCCCCTCACCAACGTCTTCAAAATCTGGTAAACTATCATCCAATTTTCTTGCCCATTTTG ATGGCTGTCGCTGCCAACAAACGTTCGGTAATGACGCTGTTTTCTGGTCCTACTGACATCTATAGCCATCAGGTCCGCATCGTGCTGGCCGAAAAAGGTGTTAGTTTTGAGATAGAGCACGTGGAGAAGGACAACCCGCCTCAGGATCTGATTGACCTCAACCCGAATCAAAGCGTACCGACGCTTGTGGATCGTGAGCTCACTCTGTGGGAATCTCGCATCATTATGGAATATCTGGATGAGCGTTTCCCGCATCCGCCGCTCATGCCGGTTTACCCGGTGGCGCGTGGGGAAAGCCGTCTGTATATGCAGCGTATCGAAAAGGACTGGTATTCGTTGATGAATACCATTCAGACCGGTACCGCTGCGCAGGCTGATACTGCGCGTAAGCAGCTGCGTGAAGAACTACAGGCGATTGCGCCAGTTTTCACCCAGAAGCCCTACTTCCTGAGCGATGAGTTCAGCCTGGTGGACTGCTACCTGGCACCACTGCTGTGGCGTCTGCCGGTTCTCGGCGTAGAGCTGGTCGGCGCTGGCGCGAAAGAGCTTAAAGGCTATATGACTCGCGTATTTGAGCGCGACTCTTTCCTCGCTTCTTTAACTGAAGCCGAACGTGAAATGCGTCTCGGTCGGGGCTAA ATGGCTGAAAATCAATACTACGGCACCGGTCGCCGCAAAAGTTCCGCAGCTCGCGTTTTCATCAAACCGGGCAACGGTAAAATCGTTATCAACCAGCGTTCTCTGGAACAGTACTTCGGTCGTGAAACTGCCCGCATGGTAGTTCGTCAGCCGCTGGAACTGGTCGACATGGTTGAGAAATTAGATCTGTACATCACCGTTAAAGGTGGTGGTATCTCTGGTCAGGCTGGTGCGATCCGTCACGGTATCACCCGCGCTCTGATGGAGTACGACGAGTCCCTGCGTGGCGAACTGCGTAAAGCTGGTTTCGTTACTCGTGATGCTCGTCAGGTTGAACGTAAGAAAGTCGGCCTGCGTAAAGCACGTCGTCGTCCTCAGTTCTCCAAACGTTAA

CDS tatE GTCAAAGCCGTATTATTCGACCCCTTAGGGACAACGCTTGCCGGGGCGGGAGAGCGGCCGCAGTTGATTTTTGCCGAACTTTCAGCTGATTATATTCAGCAGGTACGCGAGCGCCTGCCGGTGTTGCCGCAATCGCCGCTTTGCGCCACCGCAATTATTATGACGTTTTTTTAAACAAGGCTTGATTCACCTTGTTACAGATTGCTATTGTGTCCGCGGCTCAAATAGCCGTTTAATTGTG ATGGGTGAGATTAGTATTACCAAACTGCTGGTAGTCGCAGCGCTGATTATCCTGGTGTTTGGTACCAAAAAGTTACGCACGCTGGGTGGAGACCTGGGCTCGGCTATCAAAGGCTTTAAAAAAGCCATGAGCGATGACGATGACAGTGCGAAGAAGACCAGTGTGCTGAAGAAGCGCCGGCACAGAAGCTCTCTCATAAAGAGTAA ATGTTTGTTGCTGCCGGACAATTTGCCGTAACGCCGGACTGGACGGGAAACGCGCAGACCTGCGTCAGCATGATGCGCCAGGCCGCGGAGCGGGGGGCGTCGCTTCTGGTTCTGCCTGAGGCGTTGCTGGCGCGAGACGATAACGATGCGGATTTATCGGTTAAATCCGCCCAGCAGCTGGATGGCGGCTTCTTACAGCTCTTGCTGGCGGAGAGCGAAAACAGCGCTTTGACGACGGTGCTGACCCTGCATATCCCTTCCGGCGAAGGTCGAGCGACGAATACGCTGGTGGCCCTGCGTCAGGGGAAGATTGTGGCGCAATATCAGAAACTGCATCTCTATGATGCGTTCAATATCCAGGAATCCAGGCTGGTCGATGCCGGGCGGCAAATTCCGCCGCTGATCGAAGTCGACGGGATGCGCGTCGGGCTGATGACCTGCTACGATTTACGTTTCCCTGAGCTGGCGCTGTCGTTAGCGCTCAGCGGCGCGCAGCTCATAGTGTTGCCTGCCGCGTGGGTAAAAGGGCCGCTGAAGGAACATCACTGGGCGACGCTGCTGGCGGCGCGGGCGCTGGATACAACCTGCTATATTGTCGCCGCAGGAGAGTGCGGGACGCGTAATATCGGTCAAAGCCGTATTATCGACCCCTTAGGGACAACGCTTGCCGGGGCGGGAGAGCGGCCGCAGTTGATTTTTGCCGAACTTTCAGCTGATTATATTCAGCAGGTACGCGAGCGCCTGCCGGTGTTGCGCAATCGCCGCTTTGCGCCACCGCAATTATTATGA

CDS of the LexA repressor GAGGCGGTGGTTGACCGTATCGGTCCCGAGCATCATGAGCTTTCGGGGCGAGCGAAAGATATGGGATCGGCGGCGGTACTGCTGGCGATTATCATCGCGCTGATCGCGTGGGGAACCGCTGCTGTGGGCGAACTACCGCTAAGTCTTGTCGTAGCTGCTCGCAAAACGGAAAGAAACTCCTGATTTTTGTGTGAAATGTGACTGTTCCAAAATCACCGTTAGCTGTATAG ATGAAAGCGTTAACGACCAGGCAGCAAGAGGTGTTTGATCTCATTCGGGATCATATCAGCCAGACGGGCATGCCGCCGACGCGTGCGGAGATTGCTCAGCGCTTGGGGTTTCGCTCCCCAAACGCGGCGGAAGAGCATCTGAAAGCGCTGGCGCGTAAAGGCGCAATCGAGATCGTTTCCGGCGCCTCCCGCGGTATTCGTCTGCTGACGGAAGAAGAAACCGGTCTGCCGCTTATTGGCCGCGTCGCGGCAGGTGAGCCGCTGCTAGCGCAGCAGCACATTGAAGGCCACTACCAGGTGGACCCGGCCATGTTTAAGCCGAACGCCGATTTTCTGCTGCGTGTTAGCGGTATGTCGATGAAGGATATCGGTATTCTCGATGGCGACCTGCTGGCTGTCCATAAAACGCAGGATGTGCGCAATGGTCAGGTGGTTGTGGCGCGTATCGACGAAGAAGTGACCGTGAAGCGTCTGAAAAAACAGGGTAACGTCGTGGAATTGCTGCCGGAAAACAGCGAATTCTCGCCGATCGTGGTCGACCTTCGCGAACAAAGCTTTACTATTGAAGGCCTGGCCGTCGGCGTTATCCGCAACGGCAACTGGCAATAA ATGGCCAATAATACCACTGGGTTAACCCGAATTATTAAAGCGGCCGGGTATTCCTGGAAAGGATTCCGTGCGGCGTGGGTCAATGAGGCCGCATTTCGTCAGGAAGGCATCGCGGCCGTTATTGCCGTGGCGATCGCCTGCTGGTTGGACGTCGATGCCATCACGCGGGTGCTGCTCATTAGCTCGGTCCTGTTAGTGATGATAGTTGAAATTATCAATAGCGCGATTGAGGCGGTGGTTGACCGTATCGGTCCCGAGCATCATGAGCTTTCGGGGCGAGCGAAAGATATGGGATCGGCGGCGGTACTGCTGGCGATTATCATCGCGCTGATCGCGTGGGGAACGCTGCTGTGGGCGAACTACCGCTAA

CDS hisS TAAGAAAAGCGGCCTGTACGAAGACGGCGTACGTAAAAGACAGGCTGGATAACGACGATATGATCGATCAGCTGGAAGCGCGTATTCGCGCTAAAGCATCGATGCTGGATGAGGCGCGTCGTATCGATATCCAGCAGGTTGAAGCGAAATAACGTGTTGGGAAGCGATACGCTTCCCGTGTATGATTGAACCTGCGGGCGCGAGGCGCCGAAAGGTTCATTTTTAAGAATACATAACATTG ..ATGAACGATTATCTGCCGGGCGAAACCGCTCTCTGGCAGCGCATTGAAGGCTCACTGAAGCAGGTGCTTGGTAGCTACGGTTACAGCGAAATCCGTTTGCCGATTGTAGAGCAGACCCCGTTATTCAAACGCGCTATCGGCGAAGTGACCGACGTGGTTGAAAAAGAGATGTACACCTTTGAGGACCGTAACGGCGATAGCCTGACTCTACGTCCGGAAGGCACGGCTGGCTGCGTACGCGCCGGTATCGAACATGGTCTCCTGTACAATCAAGAACAGCGCCTGTGGTACATTGGGCCGATGTTCCGCCACGAACGTCCGCAAAAAGGCCGCTACCGTCAGTTCCACCAGATTGGCGCCGAAGCGTTTGGCCTGCAGGGGCCGGATATCGATGCCGAGCTGATTATGCTGACCGCCCGCTGGTGGCGCGAGCTGGGCATCTCCGGCCACGTTGCGCTGGAGCTGAACTCTATCGGTTCGCTGGAGGCTCGCGCTAACTATCGCGACGCGCTGGTGGCCTATCTTGAGCAGTTTAAAGATAAGCTGGACGAAGACTGCAAACGCCGCATGTACACCAACCCGCTGCGCGTGCTGGATTCTAAAAACCCGGACGTCCAGGCGCTGCTGAACGACGCCCCGACGCTGGGCGACTATCTTGATGAAGAGTCCAAAACGCATTTTGCCGGGCTGTGCGCGCTGCTGGATGATGCCGGTATTCGCTATACCGTGAATCAGCGTCTGGTACGCGGTCTCGACTACTACAACCGCACCGTGTTTGAGTGGGTCACCACCAGCCTCGGTTCCCAGGGCACCGTCTGCGCCGGAGGCCGTTACGATGGTCTGGTTGAGCAGCTTGGCGGTCGCGCTACCCCTGGCGTCGGCTTTGCGATGGGGCTGGAACGTCTTGTTTTACTGGTTCAGGCAGTGAATCCGGAATTTAAAGCCGATCCTGTTGTCGATATATACCTGGTAGCCTCCGGAACTGACACCCAGTCCGC AGCAATCGTCTGGCTGAACAGGTACGCGATGCGTTACCCGGCGTTAAGCTGATGACCAACCATGGCGGCGGCAACTTTAAGAAGCAGTTTGCGCGCGCTGATAAATGGGGCGCTCGCGTTGCGCTGGTGCTGGGCGAATCAGAAATCGCCGACGGAAACGTGGTAGTGAAAGATTTACGCTCAGGTGAGCAAACTACCGTAACGCAGGATAGCGTTGCACTCGTGCATTTGCG ATGCATAACCAGGCTCCGATTCAACGTAGAAAATCAAAACGAATTTACGTTGGGAATGTGCCGATTGGCGATGGCGCCCCCATCGCCGTACAGTCGATGACAAACACGCGCACCACCGATGTGGCGGCGACGGTAAATCAAATTAAAGCCCTCGAGCGCGTTGGCGCGGATATCGTGCGCGTTTCGGTGCCGACGATGGATGCGGCGGAAGCGTTCAAACTTATCAAACAGCAGGTTAACGTCCCGCTGGTTGCCGATATCCACTTCGATTACCGCATTGCGCTGAAGGTAGCGGAATACGGCGTTGATTGCCTGCGTATTAACCCGGGCAATATCGGCAACGAAGAGCGTATCCGCATGGTGGTGGACTGCGCTCGCGATAAAAATATTCCTATCCGTATCGGGGTAAACGCCGGTTCTCTGGAAAAAGATCTCCAGGAAAAATACGGCGAACCGACTCCGCAGGCGCTGCTGGAATCGGCAATGCGCCATGTTGATCATCTCGATCGTCTCAACTTCGATCAGTTTAAAGTCAGCGTAAAAGCCTCCGATGTGTTCCTCGCGGTTGAATCCTATCGCCTGTTGGCGAAACAGATCGATCAGCCTCTGCACCTCGGGATCACCGAAGCGGGCGGCGCGCGCAGCGGCGCGGTGAAGTCCGCGATCGGCCTCGGCCTGCTGCTGTCTGAAGGGATTGGCGATACGCTGCGCGTCTCTCTGGCGGCGGATCCCGTTGAAGAGATCAAAGTGGGCTTCGATATTCTCAAGTCGCTGCGTATTCGCTCTCGCGGGATCAACTTTATTGCCTGCCCGACCTGTTCACGTCAGGAGTTTGACGTTATCGGTACCGTTAACGCGCTGGAGCAGCGCCTGGAAGATATCATTACGCCGATGGATATTTCGATCATTGGCTGCGTGGTAAACGGTCCCGGCGAGGCGCTGGTTTCCACCCTCGGCGTAACCGGCGGCAATAAGAAAAGCGGCCTGTACGAAGACGGCG TACGTAAAGACAAGGCTGGATAACGACGATATGATCGATCAGCTGGAAGCGCGTATTCGCGCTAAAGCATCGATGCTGGATGAGGCGCGTCGTATCGATATCCAGCAGGTTGAAGCGAAATAA

[0181] Table of strains

Variety First indication Current title Universal name Line Description of mutant DNA Genotype Gene mutation 1 one Application text CI006 CI006 A strain isolated from the genera Enterobacter Not wt 2 Application text CI008 CI008 A strain isolated from the genera Burkholderia Not wt 3 Application text CI010 CI010 A strain isolated from the genera Klebsiella Not wt four Application text CI019 CI019 A strain isolated from the genera Rahnella Not wt 5 Application text CI028 CI028 A strain isolated from the genera Enterobacter Not wt 6 Application text CI050 CI050 A strain isolated from the genera Klebsiella Not wt 7 Application text CM002 CM002 Mutant CI050 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR ATGAGCCATATTCAACGGGAAACGTCTTGCTCCAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATAAGCCTGCCTGGTTCTGCGTTTCCCGCTCTTTAATACCCTGACCGGAGGTGAGCAATGA eight Application text CM011 CM011 Mutant CI019 Destruction of the nifL gene by a spectinomycin resistance expression cassette (SpecR) encoding an inserted streptomycin-3''-O-adenylate transferase aadA gene. ΔnifL::SpecR ATGAGCATCACGGCGTTATCAGCATCATTTCCTGAGGGGAATATCGCCAGCCGCTTGTCGCTGCAACATCCTTCACTGTTTTATACCGTGGTTGAACAATCTTCGGTGGCGAGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCCCCTCGTCCCGACACTTCCAGATCGCCATAGCGCACAGCGCCTCGAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCG CTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATGGTACCCGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCCCTTATCCAGACGCTGATCGCCCATCATCGCGGTTCTTTAGATCTCTCGGTCCGCCCTGATGGCGGCACCTTGCTGACGTTACGCCTGCCGGTACAGCAGGTTATCACCGGAGGCTTAAAATGA 9 Application text CM013 CM013 Mutant CI006 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR CTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATAAGCCTTGACCCTACGATTCCCGCTATTTCATTCA CTGACCGGAGGTTCAAAATGA ten figure 4A CM004 CM004 Mutant CI010 Destruction of the amtB gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔamtB::KanR ATGAAGATAGCAACAATGAAAACAGGTCTGGGAGCGTTGGCTCTTCTTCCCTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCCGTCCGCGCTTAAACTCCAACATGGACGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGCTTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCCGTCTCAACTGGCTGACGGAGTTTATGCCTCTCCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCGTGGTTACTCACCACCGCGATTCCTGGGAAAACAGCCTTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCCGTGTTCCTGCGCCGGTTACATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGTGTATTTCGTCTTGCTCAGGCGCAATCACGCATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCACAAGCTCTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGGGTCGGAATCGCAGACCGTTACCAGGACCTTGCCATTCTTTGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCG ATGAGTTTTTCTAATAAGCCTGTGAAGGGCTGGACGTAAACAGCCACGGCGAAAACGCCTACAACGCCTGA eleven figure 4A CM005 CM005 Mutant CI010 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR ATGACCCTGAATATGATGCTCGATAACGCCGTACCCGAGGCGATTGCCGGCTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCCGTCCGCGCTTAAACTCCAACATGGACGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGCTTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCCGTCTCAACTGGCTGACGGAGTTTATGCCTCTCCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCGTGGTTACTCACCACCGCGATTCCTGGGAAAACAGCCTTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCCGTGTTCCTGCGCCGGTTACATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGTGTATTTCGTCTTGCTCAGGCGCAATCACGCATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCACAAGCTCTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGGGTCGGAATCGCAGACCGTTACCAGGACCTTGCCATTCTTTGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCG ATGAGTTTTTCTAATAAGCCTTGGTTCTGCGTTTCCCGCTCTTTAATACCCTGACCGGAGGTGAGCAATGA 12 figure 4B CM015 CM015 Mutant CI006 Destruction of the nifL gene by an integrated fragment of the region upstream of the ompX gene (Prm5). ΔnifL::Prm5 ATGACCCTGAATATGATGATGGATGCCGGCGGACATCATCGCGACAAACAATATTAATACCGGCAACCACACCGGCAATTTACGAGACTGCGCAGGCATCCTTTCTCCCGTCAATTTCTGTCAAATAAAGTAAAAGAGGCAGTCTACTTGAATTACCCCCGGCTGGTTGAGCGTTTGTTGAAAAAAAGTAACTGAAAAATCCGTAGAATAGCGCCACTCTGATGGTTAATTAACCTATTCAATTAAGAATTATCTGGATGAATGTGCCATTAAATGCGCAGCATAATGGTGCGTTGTGCGGGAAAACTGCTTTTTTTTGAAAGGGTTGGTCAGTAGCGGAAACAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 13 figure 4B CM021 CM021 Mutant CI006 Destruction of the nifL gene by an inserted fragment of the region upstream of the unannotated gene and the first 73 b.p. this gene (Prm2). ΔnifL::Prm2 ATGACCCTGAATATGATGATGGATGCCGGCTCACCACGGCGATAACCATAGGTTTTCGGCGTGGCCACATCCATGGTGAATCCCACTTTTTCCAGCACGCGCGCCACTTCATCGGGTCTTAAATACATAGATTTTCCTCGTCATCTTTCCAAAGCCTCGCCACCTTACATGACTGAGCATGGACCGTGACTCAGAAAATTCCACAAACGAACCTGAAAGGCGTGATTGCCGTCTGGCCTTAAAAATTATGGTCTAAACTAAAATTTACATCGAAAACGAGGGAGGATCCTATGTTTAACAAACCGAATCGCCGTGACGTAGATGAAGGTGTTGAGGATATTAACCACGATGTTAACCAGCTCGAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA fourteen figure 4B CM023 CM023 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the acpP gene and the first 121 b.p. acpP gene (Prm4). ΔnifL::Prm4 ATGACCCTGAATATGATGATGGATGCCGGCTGACGAGGCAGGTTACATCACTGGTGAAACCCTGCACGTCAATGGCGGAATGTATATGGTTTAACCACGATGAAAATTATTTGCGTTATTAGGGCGAAAGGCCTCAAAATAGCGTAAAATCGTGGTAAGAACTGCCGGGATTTAGTTGCAAATTTTTCAACATTTTATACACTACGAAAACCATCGCGAAAGCGAGTTTTGATAGGAAATTTAAGAGTATGAGCACTATCGAAGAACGCGTTAAGAAAATTATCGGCGAACAGCTGGGCGTTAAGCAGGAAGAAGTTACCAACAATGCTTCCTTCGTTGAAGACCTGGGCGCTGATTCTCTTGACACCGAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA fifteen figure 10A CM014 CM014 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the lpp gene and the first 29 b.p. lpp gene (Prm1). ΔnifL::Prm1 ATGACCCTGAATATGATGATGGATGCCGGCCGTCCTGTAATAATAACCGGACAATTCGGACTGATTAAAAAAGCGCCCTTGTGGCGCTTTTTTTATATTCCCGCCTCCATTTAAAATAAAAAATCCAATCGGATTTCACTATTTAAACTGGCCATTATCTAAGATGAATCCGATGGAAGCTCGCTGTTTTAACACGCGTTTTTTAACCTTTTATTGAAAGTCGGTGCTTCTTTGAGCGAACGATCAAATTTAAGTGGATTCCCATCAAAAAAATATTCTCAACCTAAAAAAGTTTGTGTAATACTTGTAACGCTACATGGAGATTAACTCAATCTAGAGGGTATTAATAATGAATCGTACTAAACTGGTACTGGGCGCAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 16 figure 10A CM016 CM016 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the lexA gene 3 and the first 21 b.p. lexA 3 gene (Prm9). ΔnifL::Prm9 ATGACCCTGAATATGATGATGGATGCCGGCATATTGACACCATGACGCGCGTAATGCTGATTGGTTCTGTGACGCTGGTAATGATTGTCGAAATTCTGAACAGTGCCATCGAAGCCGTAGTAGACCGTATTGGTGCAGAATTCCATGAACTTTCCGGGCGGGCGAAGGATATGGGGTCGGCGGCGGTGCTGATGTCCATCCTGCTGGCGATGTTTACCTGGATCGCATTACTCTGGTCACATTTTCGATAACGCTTCCAGAATTCGATAACGCCCTGGTTTTTTGCTTAAATTTGGTTCCAAAATCGCCTTTAGCTGTATATACTCACAGCATAACTGTATATACACCCAGGGGGCGGGATGAAAGCATTAACGGCCAGGAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 17 figure 10A CM022 CM022 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the mntP 1 gene and the first 53 b.p. mntP 1 gene (Prm3). ΔnifL::Prm3 ATGACCCTGAATATGATGATGGATGCCGGCATCATATTGCGCTCCCTGGTTATCATTTGTTACTAAATGAAATGTTATAATATAACAATTATAAATACCACATCGCTTTCAATTCACCAGCCAAATGAGAGGAGCGCCGTCTGACATAGCCAGCGCTATAAAACATAGCATTATCTATATGTTTATGATTAATAACTGATTTTTGCGTTTTGGATTTGGCTGTGGCATCCTTGCCGCTCTTTTCGCAGCGTCTGCGTTTTTGCCCTCCGGTCAGGGCATTTAAGGGTCAGCAATGAGTTTTTACGCAATTACGATTCTTGCCTTCGGCATGTCGATGGATGCTTTAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA eighteen figure 10A CM024 CM024 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the sspA gene (Prm7). ΔnifL::Prm7 ATGACCCTGAATATGATGATGGATGCCGGCCGCGTCAGGTTGAACGTAAAAAAGTCGGTCTGCGCAAAGCACGTCGTCGTCCGCAGTTCTCCAAACGTTAATTGGTTTCTGCTTCGGCAGAACGATTGGCGAAAAAACCCGGTGCGAACCGGGTTTTTTTATGGATAAAGATCGTGTTATCCACAGCAATCCATTGATTATCTCTTCTTTTTCAGCATTTCCAGAATCCCCTCACCACAAAGCCCGCAAAATCTGGTAAACTATCATCCAATTTTCTGCCCAAATGGCTGGGATTGTTCATTTTTTGTTTGCCTTACAACGAGAGTGACAGTACGCGCGGGTAGTTAACTCAACATCTGACCGGTCGATAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 19 figure 10A CM025 CM025 Mutant CI006 Destruction of the nifL gene by an inserted fragment of the region upstream of the hisS gene and the first 52 bp. hisS gene (Prm10). ΔnifL::Prm10 ATGACCCTGAATATGATGATGGATGCCGGCCCTGTATGAAGATGGCGTGCGCAAAGATCGCCTGGATAACAGCGATATGATTAGCCAGCTTGAAGCCCGCATTCGCGCGAAAGCGTCAATGCTGGACGAAGCGCGTCGTATCGATGTGCAACAGGTAGAAAAATAAGGTTGCTGGGAAGCGGCAGGCTTCCCGTGTATGATGAACCCGCCCGGCGCGACCCGTTGTTCGTCGCGGCCCCGAGGGTTCATTTTTTGTATTAATAAAGAGAATAAACGTGGCAAAAAATATTCAAGCCATTCGCGGCATGAACGATTATCTGCCTGGCGAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA twenty figure 10B CM006 CM006 Mutant CI010 Destruction of the glnB gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔglnB::KanR ATGAAAAAGATTGATGCGATTATTAAACCTTTCAAACTGGATGACGTGCGCTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCCGTCCGCGCTTAAACTCCAACATGGACGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGCTTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCCGTCTCAACTGGCTGACGGAGTTTATGCCTCTCCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCGTGGTTACTCACCACCGCGATTCCTGGGAAAACAGCCTTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCCGTGTTCCTGCGCCGGTTACATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGTGTATTTCGTCTTGCTCAGGCGCAATCACGCATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCACAAGCTCTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGGGTCGGAATCGCAGACCGTTACCAGGACCTTGCCATTCTTTGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCG ATGAGTTTTTCTAATAAGCCTCGCGCGTGATTCGTATCCGCACCGGCGAAGAAGACGACGCGGCGATTTAA 21 figure 10C CI028 nifL:KanR CM017 Mutant CI028 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR ATGACCATGAACCTGATGACGGATGTCGTCTCAGCCACCGGGATCGCCGGGTTGCTTTCACGACAACACCCGACGCTGTTTTTTACACTAATTGAACAGGCCCCCGTGGCGATCACGCTGACGGATACCGCTGCCCGCATTGTCTATGCCAACCCGGGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGAC GAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATAAGCCTGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCATCGATCTGCATCCACGGTCCGGCGGCGGTACCTGCCTGACGCTACGTTTACCGCTCTTTTATGAACTGACCGGAGGCCCAAGATGA 22 figure 10C CI019 nifL:SpecR CM011 Mutant CI019 Destruction of the nifL gene by a spectinomycin resistance expression cassette (SpecR) encoding an inserted streptomycin-3''-O-adenylate transferase aadA gene. ΔnifL::SpecR ATGAGCATCACGGCGTTATCAGCATCATTTCCTGAGGGGAATATCGCCAGCCGCTTGTCGCTGCAACATCCTTCACTGTTTTATACCGTGGTTGAACAATCTTCGGTGGCGAGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCCCCTCGTCCCGACACTTCCAGATCGCCATAGCGCACAGCGCCTCGAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCG CTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATGGTACCCGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCCCTTATCCAGACGCTGATCGCCCATCATCGCGGTTCTTTAGATCTCTCGGTCCGCCCTGATGGCGGCACCTTGCTGACGTTACGCCTGCCGGTACAGCAGGTTATCACCGGAGGCTTAAAATGA 23 figure 10C CI006 nifL:KanR CM013 Mutant CI006 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR CTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATAAGCCTTGACCCTACGATTCCCGCTATTTCATTCA CTGACCGGAGGTTCAAAATGA 24 figure 10C CI010 nifL:KanR CM005 Mutant CI010 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR ATGACCCTGAATATGATGCTCGATAACGCCGTACCCGAGGCGATTGCCGGCTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCCGTCCGCGCTTAAACTCCAACATGGACGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGCTTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCCGTCTCAACTGGCTGACGGAGTTTATGCCTCTCCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCGTGGTTACTCACCACCGCGATTCCTGGGAAAACAGCCTTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCCGTGTTCCTGCGCCGGTTACATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGTGTATTTCGTCTTGCTCAGGCGCAATCACGCATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCACAAGCTCTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGGGTCGGAATCGCAGACCGTTACCAGGACCTTGCCATTCTTTGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCG ATGAGTTTTTCTAATAAGCCTTGGTTCTGCGTTTCCCGCTCTTTAATACCCTGACCGGAGGTGAGCAATGA 25 figure 4C Strain 2 CI006 A strain isolated from the genera Enterobacter Not wt 26 figure 4C Strain 4 CI010 A strain isolated from the genera Klebsiella Not wt 27 figure 4C Strain 1 CI019 A strain isolated from the genera Rahnella Not wt 28 figure 4C Strain 3 CI028 A strain isolated from the genera Enterobacter Not wt 29 figure 4B Strain 2 CI006 A strain isolated from the genera Enterobacter Not wt thirty figure 4B High CM014 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the lpp gene and the first 29 b.p. lpp gene (Prm1). ΔnifL::Prm1 ATGACCCTGAATATGATGATGGATGCCGGCCGTCCTGTAATAATAACCGGACAATTCGGACTGATTAAAAAAGCGCCCTTGTGGCGCTTTTTTTATATTCCCGCCTCCATTTAAAATAAAAAATCCAATCGGATTTCACTATTTAAACTGGCCATTATCTAAGATGAATCCGATGGAAGCTCGCTGTTTTAACACGCGTTTTTTAACCTTTTATTGAAAGTCGGTGCTTCTTTGAGCGAACGATCAAATTTAAGTGGATTCCCATCAAAAAAATATTCTCAACCTAAAAAAGTTTGTGTAATACTTGTAACGCTACATGGAGATTAACTCAATCTAGAGGGTATTAATAATGAATCGTACTAAACTGGTACTGGGCGCAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 31 figure 4B Average CM015 Mutant CI006 Destruction of the nifL gene by an integrated fragment of the region upstream of the ompX gene (Prm5). ΔnifL::Prm5 ATGACCCTGAATATGATGATGGATGCCGGCGGACATCATCGCGACAAACAATATTAATACCGGCAACCACACCGGCAATTTACGAGACTGCGCAGGCATCCTTTCTCCCGTCAATTTCTGTCAAATAAAGTAAAAGAGGCAGTCTACTTGAATTACCCCCGGCTGGTTGAGCGTTTGTTGAAAAAAAGTAACTGAAAAATCCGTAGAATAGCGCCACTCTGATGGTTAATTAACCTATTCAATTAAGAATTATCTGGATGAATGTGCCATTAAATGCGCAGCATAATGGTGCGTTGTGCGGGAAAACTGCTTTTTTTTGAAAGGGTTGGTCAGTAGCGGAAACAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 32 figure 4B Short CM023 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the acpP gene and the first 121 b.p. acpP gene (Prm4). ΔnifL::Prm4 ATGACCCTGAATATGATGATGGATGCCGGCTGACGAGGCAGGTTACATCACTGGTGAAACCCTGCACGTCAATGGCGGAATGTATATGGTTTAACCACGATGAAAATTATTTGCGTTATTAGGGCGAAAGGCCTCAAAATAGCGTAAAATCGTGGTAAGAACTGCCGGGATTTAGTTGCAAATTTTTCAACATTTTATACACTACGAAAACCATCGCGAAAGCGAGTTTTGATAGGAAATTTAAGAGTATGAGCACTATCGAAGAACGCGTTAAGAAAATTATCGGCGAACAGCTGGGCGTTAAGCAGGAAGAAGTTACCAACAATGCTTCCTTCGTTGAAGACCTGGGCGCTGATTCTCTTGACACCGAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 33 figure 4D Strain 2 CI006 A strain isolated from the genera Enterobacter None wt 34 figure 4D evolved CM029 Mutant CI006 Destruction of the nifL gene by an integrated fragment of the region upstream of the ompX gene (Prm5) and a 1287 bp deletion. after the start codon of the glnE gene containing the adenylyl-deleting domain of the adenylate transferase glutamate ammonia ligase (ΔglnE-AR_KO1). ΔnifL::Prm5 ΔglnE-AR_KO1 ATGACCCTGAATATGATGATGGATGCCGGCGGACATCATCGCGACAAACAATATTAATACCGGCAACCACACCGGCAATTTACGAGACTGCGCAGGCATCCTTTCTCCCGTCAATTTCTGTCAAATAAAGTAAAAGAGGCAGTCTACTTGAATTACCCCCGGCTGGTTGAGCGTTTGTTGAAAAAAAGTAACTGAAAAATCCGTAGAATAGCGCCACTCTGATGGTTAATTAACCTATTCAATTAAGAATTATCTGGATGAATGTGCCATTAAATGCGCAGCATAATGGTGCGTTGTGCGGGAAAACTGCTTTTTTTTGAAAGGGTTGGTCAGTAGCGGAAACAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 35 figure 14C wild type CI006 A strain isolated from the genera Enterobacter None wt 36 figure 14C evolved CM014 Mutant CI006 Destruction of the nifL gene by the built-in fragment of the region upstream of the lpp gene and the first 29 b.p. lpp gene (Prm1). ΔnifL::Prm1 ATGACCCTGAATATGATGATGGATGCCGGCCGTCCTGTAATAATAACCGGACAATTCGGACTGATTAAAAAAGCGCCCTTGTGGCGCTTTTTTTATATTCCCGCCTCCATTTAAAATAAAAAATCCAATCGGATTTCACTATTTAAACTGGCCATTATCTAAGATGAATCCGATGGAAGCTCGCTGTTTTAACACGCGTTTTTTAACCTTTTATTGAAAGTCGGTGCTTCTTTGAGCGAACGATCAAATTTAAGTGGATTCCCATCAAAAAAATATTCTCAACCTAAAAAAGTTTGTGTAATACTTGTAACGCTACATGGAGATTAACTCAATCTAGAGGGTATTAATAATGAATCGTACTAAACTGGTACTGGGCGCAACTCACTTCACACCCCGAAGGGGGAAGTTGCCTGACCCTACGATTCCCGCTATTTCATTCACTGACCGGAGGTTCAAAATGA 37 figure 14B wild type CI019 A strain isolated from the genera Rahnella None wt 38 figure 14B evolved CM011 Mutant CI019 Destruction of the nifL gene by a spectinomycin resistance expression cassette (SpecR) encoding an inserted streptomycin-3''-O-adenylate transferase aadA gene. ΔnifL::SpecR ATGAGCATCACGGCGTTATCAGCATCATTTCCTGAGGGGAATATCGCCAGCCGCTTGTCGCTGCAACATCCTTCACTGTTTTATACCGTGGTTGAACAATCTTCGGTGGCGAGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCCCCTCGTCCCGACACTTCCAGATCGCCATAGCGCACAGCGCCTCGAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCG CTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATGGTACCCGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCCCTTATCCAGACGCTGATCGCCCATCATCGCGGTTCTTTAGATCTCTCGGTCCGCCCTGATGGCGGCACCTTGCTGACGTTACGCCTGCCGGTACAGCAGGTTATCACCGGAGGCTTAAAATGA 39 figure 14A evolved CM011 Mutant CI019 Destruction of the nifL gene by a spectinomycin resistance expression cassette (SpecR) encoding an inserted streptomycin-3''-O-adenylate transferase aadA gene. ΔnifL::SpecR ATGAGCATCACGGCGTTATCAGCATCATTTCCTGAGGGGAATATCGCCAGCCGCTTGTCGCTGCAACATCCTTCACTGTTTTATACCGTGGTTGAACAATCTTCGGTGGCGAGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCCCCTCGTCCCGACACTTCCAGATCGCCATAGCGCACAGCGCCTCGAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCG CTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATGGTACCCGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCCCTTATCCAGACGCTGATCGCCCATCATCGCGGTTCTTTAGATCTCTCGGTCCGCCCTGATGGCGGCACCTTGCTGACGTTACGCCTGCCGGTACAGCAGGTTATCACCGGAGGCTTAAAATGA 40 figure 15A wild type CI006 A strain isolated from the genera Enterobacter Not wt 41 figure 15A evolved CM013 Mutant CI006 Destruction of the nifL gene by the kanamycin resistance (KanR) expression cassette encoding the built-in aph1 aminoglycoside-O-phosphotransferase gene. ΔnifL::KanR CTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCACGTTGTGTCTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCCAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATAAGCCTTGACCCTACGATTCCCGCTATTTCATTCA CTGACCGGAGGTTCAAAATGA 42 figure 15B No name CM011 Mutant CI019 Destruction of the nifL gene by a spectinomycin resistance expression cassette (SpecR) encoding an inserted streptomycin-3''-O-adenylate transferase aadA gene. ΔnifL::SpecR ATGAGCATCACGGCGTTATCAGCATCATTTCCTGAGGGGAATATCGCCAGCCGCTTGTCGCTGCAACATCCTTCACTGTTTTATACCGTGGTTGAACAATCTTCGGTGGCGAGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCCCCTCGTCCCGACACTTCCAGATCGCCATAGCGCACAGCGCCTCGAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCG CTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATGGTACCCGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCCCTTATCCAGACGCTGATCGCCCATCATCGCGGTTCTTTAGATCTCTCGGTCCGCCCTGATGGCGGCACCTTGCTGACGTTACGCCTGCCGGTACAGCAGGTTATCACCGGAGGCTTAAAATGA 43 figure 16B Strain 5 CI008 A strain isolated from the genera Burkholderia Not wt 44 figure 16B Strain 1 CM011 Mutant CI019 Destruction of the nifL gene by a spectinomycin resistance expression cassette (SpecR) encoding an inserted streptomycin-3''-O-adenylate transferase aadA gene. ΔnifL::SpecR ATGAGCATCACGGCGTTATCAGCATCATTTCCTGAGGGGAATATCGCCAGCCGCTTGTCGCTGCAACATCCTTCACTGTTTTATACCGTGGTTGAACAATCTTCGGTGGCGAGCGTGTTGAGTCATCCTGACTAGCTGAGATGAGGGCTCGCCCCCTCGTCCCGACACTTCCAGATCGCCATAGCGCACAGCGCCTCGAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCG CTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATGGTACCCGACCGGTGGTGAATTTAATCTCGCTGACGTGTAGACATTCCCTTATCCAGACGCTGATCGCCCATCATCGCGGTTCTTTAGATCTCTCGGTCCGCCCTGATGGCGGCACCTTGCTGACGTTACGCCTGCCGGTACAGCAGGTTATCACCGGAGGCTTAAAATGA 34 figure 4D evolved CM029 Mutant CI006 Destruction of the nifL gene by an integrated fragment of the region upstream of the ompX gene (Prm5) and a 1287 bp deletion. after the start codon of the glnE gene containing the adenylyl-deleting domain of the adenylate transferase glutamate ammonia ligase (ΔglnE-AR_KO1). ΔnifL::Prm5 ΔglnE-AR_KO1 ATGTTTAACGATCTGATTGGCGATGATGAAACGGATTCGCCGGAAGATGCGCTTTCTGAGAGCTGGCGCGAATTGTGGCAGGATGCGTTGCAGGAGGAGGATTCCACGCCCGTGCTGGCGCATCTCTCAGAGGACGATCGCCGCCGCGTGGTGGCGCTGATTGCCGATTTTCGCAAAGAGTTGGATAAACGCACCATTGGCCCGCGAGGGCGGCAGGTACTCGATCACTTAATGCCGCATCTGCTCAGCGATGTATGCTCGCGCGACGATGCGCCAGTACCGCTGTCACGCCTGACGCCGCTGCTCACCGGAATTATTACCCGCACCACTTACCTTGAGCTGCTAAGTGAATTTCCCGGCGCACTGAAACACCTCATTTCCCTGTGTGCCGCGTCGCCGATGGTTGCCAGTCAGCTGGCGCGCTACCCGATCCTGCTTGATGAATTGCTCGACCCGAATACGCTCTATCAACCGACGGCGATGAATGCCTATCGCGATGAGCTGCGCCAATACCTGCTGCGCGTGCCGGAAGATGATGAAGAGCAACAGCTTGAGGCGCTGCGGCAGTTTAAGCAGGCGCAGTTGCTGCGCGTGGCGGCGGCGGATATTGCCGGTACGTTGCCAGTAATGAAAGTGAGCGATCACTTAACCTGGCTGGCGGAAGCGATTATTGATGCGGTGGTGCAGCAAGCCTGGGGGCAGATGGTGGCGCGTTATGGCCAGCCAACGCATCTGCACGATCGCGAAGGGCGCGGTTTTGCGGTGGTCGGTTATGGCAAGCTGGGCGGCTGGGAGCTGGGTTACAGCTCCGATCTGGATCTGGTATTCCTGCACGACTGCCCGATGGATGTGATGACCGATGGCGAGCGTGAAATCGATGGTCGCCAGTTCTATTTGCGTCTCGCGCAGCGCGTGATGCACCTGTTTAGCACGCGCACGTCGTCCGGCATCCTTTATGAAGTTGATGCGCGTCTGCGTCCATCTGGCGCTGCGGGGATGC TGGTCACTACTACGGAATCGTTCGCCGATTACCAGCAAAACGAAGCCTGGACGTGGGAACATCAGGCGCTGGCCCGTGCGCGCGTGGTGTACGGCGATCCGCAACTGACCGCCGAATTTGACGCCATTCGCCGCGATATTCTGATGACGCCTCGCGACGGCGCAACGCTGCAAACCGACGTGCGAGAAATGCGCGAGAAAATGCGTGCCCATCTTGGCAACAAGCATAAAGACCGCTTCGATCTGAAAGCCGATGAAGGCGGTATCACCGACATCGAGTTTATCGCCCAATATCTGGTGCTGCGCTTTGCCCATGACAAGCCGAAACTGACGCGCTGGTCGGATAATGTGCGCATTCTCGAAGGGCTGGCGCAAAACGGCATCATGGAGGAGCAGGAAGCGCAGGCATTGACGCTGGCGTACACCACATTGCGTGATGAGCTGCACCACCTGGCGCTGCAAGAGTTGCCGGGACATGTGGCGCTCTCCTGTTTTGTCGCCGAGCGTGCGCTTATTAAAACCAGCTGGGACAAGTGGCTGGTGGAACCGTGCGCCCCGGCGTAA

Notwithstanding the appended claims, the description given herein is also defined by the following paragraphs:

1. A method for obtaining one or more bacteria, including:

(a) isolating the bacteria from the tissue or soil of the first plant;

(b) introducing a genetic variation into one or more bacteria to produce one or more bacterial variants;

(c) exposure of bacterial variants to a plurality of plants;

(d) isolating the bacteria from the tissue or soil of one of the plurality of plants, wherein the plant from which the bacteria is isolated has an improved trait relative to other plants in the plurality of plants; and

(e) repeating steps (b)-(d) with the bacteria isolated in step (d).

2. The method of claim 1, wherein the improved feature is improved nitrogen fixation in the plant from which the bacteria are isolated.

3. The method according to claim 1, where the genetic variation is a variation in a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glnA, glnB, glnK, draT, amtB, glnD, glnE, nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ.

4. The method of claim 1, wherein the genetic variation is a variation in a gene encoding a protein with a functionality selected from the group consisting of: glutamine synthetase, glutaminase, glutamine synthetase adenylate transferase, transcription activator, transcription antiactivator, pyruvate:flavodoxin oxidoreductase, flavodoxin, or ADP-D-ribosyltransferase NAD ⁺ :dinitrogenase reductase.

5. The method according to p. 1, where the genetic variation is a mutation that leads to one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity.

6. The method of claim 1, wherein the genetic variation is a knockout mutation.

7. The method of claim. 1, where the genetic variation leads to the elimination or abolition of the activity of the protein domain.

8. The method of claim 1, wherein the genetic variation comprises altering or deleting a regulatory sequence of a target gene.

9. The method of claim 1 wherein the genetic variation comprises the insertion of a heterologous regulatory sequence.

10. The method of claim. 1, where the genetic variation includes the insertion of a regulatory sequence identified in the genome of the species or genus of bacteria corresponding to the bacteria in which the genetic variation is carried out.

11. The method of claim 10, wherein the regulatory sequence is selected based on the level of gene expression in the bacterial culture or plant tissue.

12. The method of claim. 1, where the genetic variation is obtained through chemical mutagenesis.

13. The method of claim 1 wherein step (c) further comprises exposing the plants to biotic or abiotic stress factors.

14. The method of claim 2, wherein the bacteria isolated after repeating steps (b) to (d) once or multiple times produce 1% or more nitrogen in a second plant of the same type as the first plant.

15. The method of claim 2, wherein the bacteria isolated after repeating steps (b)-(d) once or multiple times show at least a 2-fold increase in nitrogen fixation compared to bacteria isolated from the first plant.

16. The method of claim 14, wherein the second plant is grown in the presence of a fertilizer supplemented with glutamine, ammonia, or other chemical nitrogen source.

17. The method of claim 1 wherein the first plant is a crop.

18. The method of claim 17 wherein the crop is selected from barley, rice, corn, wheat, sorghum, sweet corn, sugar cane, onions, tomatoes, strawberries, or asparagus.

19. The method of claim 1, wherein the first or the plants in the plurality of plants are model plants.

20. The method of claim 19 wherein the model plant is selected from Setaria , Brachypodium or Arabidopsis .

21. The method of claim 1, wherein the genetic variation is a predetermined genetic variation that is specifically carried out at the target site.

22. The method of claim 1, wherein the genetic variation is a random mutation at the target site.

23. The method of claim 1, wherein step (a) further comprises performing a genetic analysis of the isolated bacteria.

24. The method of claim 1, wherein step (b) further comprises applying selection pressure to enrich for bacteria carrying the genetic variation.

25. The method of claim 24, wherein the selection pressure comprises cleavage of genomes with no genetic variation introduced at the target site, where the cleavage occurs within 100 nucleotides of the target site.

26. The method of claim 24, further comprising isolating bacteria that have undergone selection pressure.

27. The method of claim 25, wherein the cleavage is carried out with a site-specific nuclease selected from the group consisting of zinc finger nuclease, CRISPR nuclease, TALE nuclease, or meganuclease.

28. The method of claim 27, wherein the site-specific nuclease is a CRISPR nuclease.

29. The method of claim 1 wherein the genetic variation is an insertion or deletion of one or more nucleotides.

30. The method of claim. 1, where the bacteria isolated after a single or multiple repetition of steps (b)-(d) are endophytic, epiphytic or rhizospheric.

31. The method of claim. 1, where the bacteria isolated after a single or multiple repetition of steps (b)-(d), include many bacteria of different taxa.

32. The method of claim 1, wherein the bacteria are isolated from plant tissue.

33. The method of claim 1 wherein isolating the bacteria in step (a) comprises isolating the bacteria from the seeds of the first plant.

34. A method of increasing nitrogen fixation in a plant, comprising exposing the plant to bacteria carrying one or more genetic variations introduced into one or more genes that regulate nitrogen fixation, where the bacteria produce 1% or more nitrogen in the plant.

35. The method of claim 34, wherein the bacteria produce 5% or more nitrogen in the plant.

36. The method of claim 34, wherein the bacteria produce 10% or more nitrogen in the plant.

37. The method of claim 34, wherein the bacteria produce nitrogen in the presence of a fertilizer supplemented with glutamine, ammonia, or other chemical source of supplemental nitrogen.

38. The method according to claim 34, where the genetic variation is a variation in a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glutamine synthetase, glnA, glnB, glnK, draT, amtB, glutaminase, glnD, glnE, nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ.

39. The method according to p. 34, where the genetic variation is a mutation that leads to one or more of: increased expression or activity of NifA or glutaminase; reduced expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity.

40. The method according to p. 34, where the genetic variation (a) is a knockout mutation; (b) alters or deletes the regulatory sequence of the target gene; or (c) includes the insertion of a heterologous regulatory sequence.

41. The method according to claim 34, wherein the bacteria are bacteria of the genus Enterobacter .

42. The method of claim 34, wherein the bacteria are bacteria of the genus Rahnella .

43. The method of claim 34, wherein the bacteria are endophytic, epiphytic, or rhizospheric.

44. The method of claim 34, wherein the bacteria comprise a plurality of bacteria of various taxa.

45. The method of claim 34, wherein the plant is a crop.

46. The method according to any one of paragraphs. 34-45, where the plant is a non-legume plant.

47. The method of claim 45 wherein the crop is selected from sorghum, canola, tomato, strawberry, barley, rice, corn and wheat.

48. The method of claim 45, wherein the plant is a genetically modified organism (GMO).

49. The method of claim 45, wherein the plant is not a genetically modified organism (GMO).

50. The method of claim 45, wherein the plant is genetically engineered or bred to use nitrogen efficiently.

51. A population of bacteria containing bacteria carrying one or more genetic variations introduced into one or more genes that regulate nitrogen fixation, where the bacteria produce in a plant grown in the presence of a population of bacteria, 1% or more nitrogen.

52. The bacterial population of claim 51, wherein the bacteria produce nitrogen in the presence of a fertilizer supplemented with glutamine, ammonia, or other chemical source of supplemental nitrogen.

53. A population of bacteria according to claim 51, where the genetic variation is a variation in a gene selected from the group consisting of: nifA, nifL, ntrB, ntrC, glutamine synthetase, glnA, glnB, glnK, draT, amtB, glutaminase, glnD, glnE , nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, and nifQ.

54. A population of bacteria according to claim 51, where the genetic variation is a mutation that leads to one or more of: increased expression of nifA or glutaminase; reduced expression of nifL, ntrB, glutamine synthetase, glnB, glnK, draT, amtB; reduced GlnE adenylate scavenging activity; or reduced GlnD uridylate scavenging activity.

55. A population of bacteria according to claim 51, where the genetic variation (a) is a knockout mutation; (b) alters or deletes the regulatory sequence of the target gene; or (c) includes the insertion of a heterologous regulatory sequence.

56. The bacterial population of claim 51, wherein the bacteria are Enterobacter .

57. The bacterial population of claim 51, wherein the bacteria are Rahnella .

58. The population of bacteria according to claim 51, where the bacteria are endophytic, epiphytic or rhizospheric.

59. The bacterial population of claim 51, wherein the bacteria include a plurality of bacteria of various taxa.

60. Composition containing a population of bacteria according to any one of paragraphs. 51-59.

61. The composition according to claim 60, where the composition contains a population of bacteria applied to the surface of the seeds.

62. The composition of claim 60, wherein the composition is formulated as a liquid or powder.

63. Bacterium with deposit access number ATCC of PTA-122293 or PTA-122294.

Claims (25)

1. A composition for increasing nitrogen fixation in non-legumes, comprising: non-intergeneric diazotrophic bacteria comprising at least one genetic variation introduced into the nitrogen fixation genetic regulatory network or nitrogen assimilation genetic regulatory network that results in one or more of the following: increased expression or activity of nifH, increased expression or activity of nifA, reduced expression or activity of nifL and reduced activity of bifunctional glutamine synthetase to remove adenylyltransferase or adenylate, wherein at least one genetic variation includes genetic material derived from the same genus as said non-intergeneric diazotrophic bacteria, and wherein one or more genetic variations (A ) is a knockout mutation, (B) alteration or deletion of the regulatory sequence of the target gene, or (C) involves the insertion of a heterologous regulatory sequence; and plant seed. 2. A composition according to claim 1, wherein said plant seed is the seed of a non-legume plant. 3. A composition according to claim 1, wherein said plant seed is a seed of a cereal plant. 4. The composition of claim 1, wherein said plant seed is a plant seed selected from the group consisting of corn, wheat, rice and sorghum. 5. The composition of claim 1 wherein said non-intergeneric diazotrophic bacteria are present as a coating on said plant seed. 6. The composition of claim 5, wherein said non-intergeneric diazotrophic bacteria reside within a seed coat that is applied to a portion of said plant seed. 7. The composition of claim 1 wherein said non-intergeneric diazotrophic bacteria are engineered bacteria. 8. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria comprise a genetic variation introduced into the nitrogen fixation genetic regulatory network. 9. The composition of claim 8, wherein said genetic variation alters the activity or expression of a gene selected from the group consisting of nifA, nifL and nifH. 10. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria comprise a genetic variation introduced into the nitrogen assimilation genetic regulatory network. 11. The composition of claim 10, wherein said genetic variation alters the activity or expression of glnE. 12. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria further comprise a genetic variation that alters the activity or expression of a gene selected from the group consisting of amtB, ntrB, ntrC, a polynucleotide encoding glutamine synthetase, glnA, glnB, glnK, drat, a polynucleotide encoding glutaminase, and glnD. 13. The composition of claim 1, wherein said genetic material derived from the same genus as said non-intergeneric diazotrophic bacteria contains a regulatory element. 14. The composition of claim 13, wherein said regulatory element is a promoter. 15. The composition of claim 14 wherein said promoter is active in the presence of exogenous nitrogen. 16. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria have increased nitrogen fixation activity in the presence of at least 0.01 mM fixed nitrogen compared to unmodified diazotrophic bacteria of said same species as said non-intergeneric diazotrophic bacteria in the presence of the same concentration of fixed nitrogen. 17. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria have at least a two-fold increase in nitrogen fixation activity in a field containing exogenous nitrogen compared to unmodified diazotrophic bacteria of said same genus as said non-intergeneric diazotrophic bacteria in the specified field. 18. The composition of claim 17 wherein said field has a fixed nitrogen concentration of at least 0.01 mM. 19. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria is an epiphyte. 20. The composition of claim 1 wherein said non-intergeneric diazotrophic bacteria is an endophyte. 21. The composition of claim 1, wherein said non-intergeneric diazotrophic bacteria is a rhizophyte. 22. The composition of claim 1, wherein said genetic material of said non-intergeneric diazotrophic bacteria does not contain genetic material derived from a different genus than said non-intergeneric diazotrophic bacteria. 23. The composition of claim 1, wherein said genetic material of said non-intergeneric diazotrophic bacteria does not contain genetic material derived from a different species than said non-intergeneric diazotrophic bacteria.

Images